BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 043200
(150 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 80.5 bits (197), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 42/96 (43%), Positives = 63/96 (65%), Gaps = 4/96 (4%)
Query: 56 RYSFPNVKKMTNSF--KDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE--FINEV 111
R+S ++ +++F K+ LG+GG+G+VYKG+L+DG LVAVK L + G E F EV
Sbjct: 19 RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 112 ASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
IS H N++ L GFC+ ++R L+Y +M NGS+
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 80.1 bits (196), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 42/96 (43%), Positives = 63/96 (65%), Gaps = 4/96 (4%)
Query: 56 RYSFPNVKKMTNSF--KDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE--FINEV 111
R+S ++ +++F K+ LG+GG+G+VYKG+L+DG LVAVK L + G E F EV
Sbjct: 27 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 112 ASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
IS H N++ L GFC+ ++R L+Y +M NGS+
Sbjct: 87 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 65.5 bits (158), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 39/104 (37%), Positives = 62/104 (59%), Gaps = 14/104 (13%)
Query: 57 YSFPNVKKMTNSFKD--------ELGQGGYGRVYKGKLSDGRLVAVKLLN-----TSKGN 103
+SF +K +TN+F + ++G+GG+G VYKG +++ VAVK L T++
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 104 GQEFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
Q+F E+ +++ H N+V LLGF +G L+Y +MPNGSL
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 65.5 bits (158), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 39/104 (37%), Positives = 62/104 (59%), Gaps = 14/104 (13%)
Query: 57 YSFPNVKKMTNSFKD--------ELGQGGYGRVYKGKLSDGRLVAVKLLN-----TSKGN 103
+SF +K +TN+F + ++G+GG+G VYKG +++ VAVK L T++
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 104 GQEFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
Q+F E+ +++ H N+V LLGF +G L+Y +MPNGSL
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 65.5 bits (158), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 39/104 (37%), Positives = 62/104 (59%), Gaps = 14/104 (13%)
Query: 57 YSFPNVKKMTNSFKD--------ELGQGGYGRVYKGKLSDGRLVAVKLLN-----TSKGN 103
+SF +K +TN+F + ++G+GG+G VYKG +++ VAVK L T++
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 104 GQEFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
Q+F E+ +++ H N+V LLGF +G L+Y +MPNGSL
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 60.1 bits (144), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 59/104 (56%), Gaps = 14/104 (13%)
Query: 57 YSFPNVKKMTNSFKD--------ELGQGGYGRVYKGKLSDGRLVAVKLLN-----TSKGN 103
+SF +K +TN+F + + G+GG+G VYKG +++ VAVK L T++
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 104 GQEFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
Q+F E+ ++ H N+V LLGF +G L+Y + PNGSL
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 59.3 bits (142), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 45/122 (36%), Positives = 68/122 (55%), Gaps = 10/122 (8%)
Query: 34 KATKSDQDLEAFIRNYVSLAP-ERYSFP--NVKKMTNSFKDE--LGQGGYGRVYKGKLSD 88
KAT S D A +Y L P E Y P ++++ TN+F + +G G +G+VYKG L D
Sbjct: 7 KATNSIND--ALSSSY--LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 89 GRLVAVKLLNTSKGNGQEFINEVAS-ISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
G VA+K G E +S H ++V+L+GFC E ++ LIY++M NG+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 148 EK 149
++
Sbjct: 123 KR 124
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 59.3 bits (142), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 45/122 (36%), Positives = 68/122 (55%), Gaps = 10/122 (8%)
Query: 34 KATKSDQDLEAFIRNYVSLAP-ERYSFP--NVKKMTNSFKDE--LGQGGYGRVYKGKLSD 88
KAT S D A +Y L P E Y P ++++ TN+F + +G G +G+VYKG L D
Sbjct: 7 KATNSIND--ALSSSY--LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 89 GRLVAVKLLNTSKGNGQEFINEVAS-ISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
G VA+K G E +S H ++V+L+GFC E ++ LIY++M NG+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 148 EK 149
++
Sbjct: 123 KR 124
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 57.0 bits (136), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 7/97 (7%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKL------SDGRLVAVKLLNTSKGNG-QEFINEVAS 113
++K+ K ELG+G +G+V+ + D LVAVK L + N ++F E
Sbjct: 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 114 ISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ H ++V G C+EG +++E+M +G L KF
Sbjct: 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 56.2 bits (134), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F E+G G +G V+ G + VA+K + + ++FI E + + SH +V L G
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
CLE + L++EFM +G L +
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDY 90
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 55.8 bits (133), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F E+G G +G V+ G + VA+K + + ++FI E + + SH +V L G
Sbjct: 13 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
CLE + L++EFM +G L +
Sbjct: 73 VCLEQAPICLVFEFMEHGCLSDY 95
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 55.8 bits (133), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F E+G G +G V+ G + VA+K + + ++FI E + + SH +V L G
Sbjct: 10 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
CLE + L++EFM +G L +
Sbjct: 70 VCLEQAPICLVFEFMEHGCLSDY 92
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 55.8 bits (133), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 45/83 (54%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F E+G G +G V+ G + VA+K + + ++FI E + + SH +V L G
Sbjct: 10 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
CLE + L++EFM +G L +
Sbjct: 70 VCLEQAPICLVFEFMEHGCLSDY 92
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 55.1 bits (131), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 44/83 (53%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F E+G G +G V+ G + VA+K + + +FI E + + SH +V L G
Sbjct: 30 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
CLE + L++EFM +G L +
Sbjct: 90 VCLEQAPICLVFEFMEHGCLSDY 112
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 54.7 bits (130), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKL------SDGRLVAVKLL-NTSKGNGQEFINEVAS 113
++K+ K ELG+G +G+V+ + D LVAVK L S+ Q+F E
Sbjct: 14 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 73
Query: 114 ISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ H ++V G C EG +++E+M +G L +F
Sbjct: 74 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 110
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 54.7 bits (130), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 21 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 81 GVCTREPPFYIIIEFMTYGNL 101
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 54.7 bits (130), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKL------SDGRLVAVKLL-NTSKGNGQEFINEVAS 113
++K+ K ELG+G +G+V+ + D LVAVK L S+ Q+F E
Sbjct: 8 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 67
Query: 114 ISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ H ++V G C EG +++E+M +G L +F
Sbjct: 68 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 104
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 54.3 bits (129), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 21 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 81 GVCTREPPFYIITEFMTYGNL 101
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 54.3 bits (129), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 76 GVCTREPPFYIIIEFMTYGNL 96
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 54.3 bits (129), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 17 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 77 GVCTREPPFYIIIEFMTYGNL 97
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 54.3 bits (129), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 76 GVCTREPPFYIITEFMTYGNL 96
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 54.3 bits (129), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 27/83 (32%), Positives = 44/83 (53%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F E+G G +G V+ G + VA+K + + ++FI E + + SH +V L G
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
CLE + L+ EFM +G L +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDY 93
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 54.3 bits (129), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 80 GVCTREPPFYIITEFMTYGNL 100
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 54.3 bits (129), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 76 GVCTREPPFYIITEFMTYGNL 96
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 54.3 bits (129), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 21 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 81 GVCTREPPFYIITEFMTYGNL 101
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 54.3 bits (129), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 14 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 74 GVCTREPPFYIIIEFMTYGNL 94
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 54.3 bits (129), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 18 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 78 GVCTREPPFYIITEFMTYGNL 98
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 54.3 bits (129), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 17 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 77 GVCTREPPFYIITEFMTYGNL 97
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 76 GVCTREPPFYIIIEFMTYGNL 96
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 76 GVCTREPPFYIITEFMTYGNL 96
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 18 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 78 GVCTREPPFYIITEFMTYGNL 98
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 18 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 78 GVCTREPPFYIITEFMTYGNL 98
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 29 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 89 GVCTREPPFYIITEFMTYGNL 109
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 14 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 74 GVCTREPPFYIITEFMTYGNL 94
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKL------SDGRLVAVKLL-NTSKGNGQEFINEVAS 113
++K+ K ELG+G +G+V+ + D LVAVK L S+ Q+F E
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 114 ISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ H ++V G C EG +++E+M +G L +F
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 21 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 81 GVCTREPPFYIITEFMTYGNL 101
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 76 GVCTREPPFYIITEFMTYGNL 96
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 53.9 bits (128), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 21 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 81 GVCTREPPFYIITEFMTYGNL 101
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 53.5 bits (127), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 31/81 (38%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY G L VAVK L +EF+ E A + H N+V LL
Sbjct: 35 TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 94
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C ++ E+MP G+L
Sbjct: 95 GVCTLEPPFYIVTEYMPYGNL 115
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 53.1 bits (126), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 283 GVCTREPPFYIITEFMTYGNL 303
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 53.1 bits (126), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 220 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 279
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 280 GVCTREPPFYIITEFMTYGNL 300
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 52.8 bits (125), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 32/81 (39%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G YG VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 322 GVCTREPPFYIITEFMTYGNL 342
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 52.4 bits (124), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/81 (38%), Positives = 41/81 (50%), Gaps = 1/81 (1%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+ K +LG G +G VY+G L VAVK L +EF+ E A + H N+V LL
Sbjct: 14 TMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G C +I EFM G+L
Sbjct: 74 GVCTREPPFYIITEFMTYGNL 94
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 50.4 bits (119), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKL------SDGRLVAVKLL-NTSKGNGQEFINEVAS 113
++K+ K ELG+G +G+V+ + D LVAVK L + + ++F E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 114 ISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ H ++V G C +G +++E+M +G L KF
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 107
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 50.1 bits (118), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGRLV----AVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G V A+K+LN + G EF++E ++ H ++V L
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
LG CL + + L+ + MP+G L ++
Sbjct: 83 LGVCLSPTIQ-LVTQLMPHGCLLEY 106
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 50.1 bits (118), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 12/90 (13%)
Query: 73 LGQGGYGRVYKGKL--SDGRLVAV-----KLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
LG+G +G V +G L DG + V KL N+S+ +EF++E A + SH NV+ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 126 LGFCLEGS-----KRALIYEFMPNGSLEKF 150
LG C+E S K +I FM G L +
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTY 131
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 50.1 bits (118), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 49/85 (57%), Gaps = 8/85 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGRLV----AVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G V A+K+LN + G EF++E ++ H ++V L
Sbjct: 46 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
LG CL + + L+ + MP+G L ++
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEY 129
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 49.3 bits (116), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 10/91 (10%)
Query: 69 FKDELGQGGYGRVYKGKL------SDGRLVAVKLLNTSKGNG---QEFINEVASISRTSH 119
F +ELG+ +G+VYKG L + VA+K L K G +EF +E +R H
Sbjct: 30 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQH 88
Query: 120 VNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
NVV LLG + ++I+ + +G L +F
Sbjct: 89 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 119
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 49.3 bits (116), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 10/91 (10%)
Query: 69 FKDELGQGGYGRVYKGKL------SDGRLVAVKLLNTSKGNG---QEFINEVASISRTSH 119
F +ELG+ +G+VYKG L + VA+K L K G +EF +E +R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQH 71
Query: 120 VNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
NVV LLG + ++I+ + +G L +F
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 49.3 bits (116), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 39/80 (48%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F ELG G +G V GK VA+K++ + EFI E + SH +V L G
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 128 FCLEGSKRALIYEFMPNGSL 147
C + +I E+M NG L
Sbjct: 67 VCTKQRPIFIITEYMANGCL 86
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 39/80 (48%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F ELG G +G V GK VA+K++ + EFI E + SH +V L G
Sbjct: 12 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 128 FCLEGSKRALIYEFMPNGSL 147
C + +I E+M NG L
Sbjct: 72 VCTKQRPIFIITEYMANGCL 91
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 39/80 (48%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F ELG G +G V GK VA+K++ + EFI E + SH +V L G
Sbjct: 12 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 128 FCLEGSKRALIYEFMPNGSL 147
C + +I E+M NG L
Sbjct: 72 VCTKQRPIFIITEYMANGCL 91
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 39/80 (48%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F ELG G +G V GK VA+K++ + EFI E + SH +V L G
Sbjct: 11 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 128 FCLEGSKRALIYEFMPNGSL 147
C + +I E+M NG L
Sbjct: 71 VCTKQRPIFIITEYMANGCL 90
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 72 ELGQGGYGRVYKGKLSD-GRLVAVKLLNT-SKGNGQEFINEVASISRTSHVNVVTLLGFC 129
ELG G +G+VYK K + G L A K++ T S+ +++I E+ ++ H +V LLG
Sbjct: 18 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 130 LEGSKRALIYEFMPNGSLE 148
K ++ EF P G+++
Sbjct: 78 YHDGKLWIMIEFCPGGAVD 96
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 53 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 113 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 141
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 39/80 (48%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F ELG G +G V GK VA+K++ + EFI E + SH +V L G
Sbjct: 18 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 128 FCLEGSKRALIYEFMPNGSL 147
C + +I E+M NG L
Sbjct: 78 VCTKQRPIFIITEYMANGCL 97
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 39/80 (48%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F ELG G +G V GK VA+K++ + EFI E + SH +V L G
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 128 FCLEGSKRALIYEFMPNGSL 147
C + +I E+M NG L
Sbjct: 87 VCTKQRPIFIITEYMANGCL 106
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 39/80 (48%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+F ELG G +G V GK VA+K++ + EFI E + SH +V L G
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 128 FCLEGSKRALIYEFMPNGSL 147
C + +I E+M NG L
Sbjct: 87 VCTKQRPIFIITEYMANGCL 106
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 48.9 bits (115), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 72 ELGQGGYGRVYKGKLSD-GRLVAVKLLNT-SKGNGQEFINEVASISRTSHVNVVTLLGFC 129
ELG G +G+VYK K + G L A K++ T S+ +++I E+ ++ H +V LLG
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 130 LEGSKRALIYEFMPNGSLE 148
K ++ EF P G+++
Sbjct: 86 YHDGKLWIMIEFCPGGAVD 104
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 32 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 92 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 120
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 33 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 93 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 121
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 34 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 94 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 122
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 34 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 94 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 122
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 34 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 94 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 122
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 89 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 117
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 34 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 94 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 122
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 52 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 112 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 140
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 91 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 119
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 26 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 86 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 114
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGK------LSDGRLVAVKLL--NTSKGNGQEFINEVASISRTSHVNVV 123
++G+G +GRV++ + +VAVK+L S +F E A ++ + N+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG C G L++E+M G L +F
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEF 140
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 39 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 99 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 127
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 33 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 93 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 121
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 35 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 95 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 123
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 153 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 181
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 48.5 bits (114), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 32 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 92 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 120
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 69 FKDELGQGGYGRVYKGKL--SDGRLV--AVKLLN--TSKGNGQEFINEVASISRTSHVNV 122
F + +G+G +G VY G L +DG+ + AVK LN T G +F+ E + SH NV
Sbjct: 35 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 123 VTLLGFCL--EGSKRALIYEFMPNGSLEKF 150
++LLG CL EGS ++ +M +G L F
Sbjct: 95 LSLLGICLRSEGSP-LVVLPYMKHGDLRNF 123
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 48.1 bits (113), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 59 FPNVKKMTNSFKDELGQGGYGRVYKGKL-SDGRLVAVK--LLNTSKGNG------QEFIN 109
P + ++ ++G+GG+G V+KG+L D +VA+K +L S+G QEF
Sbjct: 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 110 EVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
EV +S +H N+V L G L + ++ EF+P G L
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDL 108
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 48.1 bits (113), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 59 FPNVKKMTNSFKDELGQGGYGRVYKGKL-SDGRLVAVK--LLNTSKGNG------QEFIN 109
P + ++ ++G+GG+G V+KG+L D +VA+K +L S+G QEF
Sbjct: 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 110 EVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
EV +S +H N+V L G L + ++ EF+P G L
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDL 108
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 48.1 bits (113), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 11/98 (11%)
Query: 59 FPNVKKMTNSFKDELGQGGYGRVYKGKL-SDGRLVAVK--LLNTSKGNG------QEFIN 109
P + ++ ++G+GG+G V+KG+L D +VA+K +L S+G QEF
Sbjct: 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 110 EVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
EV +S +H N+V L G L + ++ EF+P G L
Sbjct: 73 EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDL 108
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 47.4 bits (111), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQ---EFINEVASISRTSHVNVVT 124
+ K+++G G +G V++ + G VAVK+L + + EF+ EVA + R H N+V
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G + +++ E++ GSL +
Sbjct: 99 FMGAVTQPPNLSIVTEYLSRGSLYRL 124
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 47.0 bits (110), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSF 124
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 47.0 bits (110), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQ---EFINEVASISRTSHVNVVT 124
+ K+++G G +G V++ + G VAVK+L + + EF+ EVA + R H N+V
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G + +++ E++ GSL +
Sbjct: 99 FMGAVTQPPNLSIVTEYLSRGSLYRL 124
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 47.0 bits (110), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSF 138
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 47.0 bits (110), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 3/75 (4%)
Query: 71 DELGQGGYGRVYKGKLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+++G+G YG VYK K S GR+VA+K L +G I E++ + H N+V+L+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 128 FCLEGSKRALIYEFM 142
L++EFM
Sbjct: 87 VIHSERCLTLVFEFM 101
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 3/75 (4%)
Query: 71 DELGQGGYGRVYKGKLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
+++G+G YG VYK K S GR+VA+K L +G I E++ + H N+V+L+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 128 FCLEGSKRALIYEFM 142
L++EFM
Sbjct: 87 VIHSERCLTLVFEFM 101
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSF 150
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSF 123
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSF 124
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSF 124
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSF 115
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSF 130
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSF 140
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSF 138
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 46.6 bits (109), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSF 123
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 46.6 bits (109), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSF 164
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 46.6 bits (109), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSF 141
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 46.2 bits (108), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLS------DGRLVAVKLLNT--SKGNGQEFINEVASISRTSHVNVVT 124
LG G +G VY+G++S VAVK L S+ + +F+ E IS+ +H N+V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
+G L+ R ++ E M G L+ F
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSF 138
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 46.2 bits (108), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 38/120 (31%), Positives = 58/120 (48%), Gaps = 20/120 (16%)
Query: 49 YVSLAPERYSFPNV----------KKMTNSFKDELGQGGYGRVYKG------KLSDGRLV 92
Y S+ PE +S +V +K+T S ELGQG +G VY+G K V
Sbjct: 23 YASVNPEYFSAADVYVPDEWEVAREKITMS--RELGQGSFGMVYEGVAKGVVKDEPETRV 80
Query: 93 AVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
A+K +N + + EF+NE + + + +VV LLG +G +I E M G L+ +
Sbjct: 81 AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 140
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 46.2 bits (108), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 130 LEGSKRALIYEFMPNGSL 147
+ A++ ++ SL
Sbjct: 74 -TAPQLAIVTQWCEGSSL 90
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 130 LEGSKRALIYEFMPNGSL 147
+ A++ ++ SL
Sbjct: 90 T-APQLAIVTQWCEGSSL 106
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 19/116 (16%)
Query: 52 LAPERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKG--KLSDGRLVAVKL-- 96
+ PE Y PN + + F EL G G +G V G KL R VAV +
Sbjct: 21 IDPETYEDPN--RAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKT 78
Query: 97 --LNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++ ++F+ E + + + H NVV L G G ++ EFM NG+L+ F
Sbjct: 79 LKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF 134
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 7/85 (8%)
Query: 73 LGQGGYGRVYKG--KLSDGR---LVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTL 125
+G G +G VYKG K S G+ VA+K L Q +F+ E + + SH N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
G + +I E+M NG+L+KF
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKF 136
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 18 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 76 TK-PQLAIVTQWCEGSSL 92
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 36 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 94 TK-PQLAIVTQWCEGSSL 110
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 20 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 78 TK-PQLAIVTQWCEGSSL 94
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 43 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 101 TK-PQLAIVTQWCEGSSL 117
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 74 TK-PQLAIVTQWCEGSSL 90
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 74 TK-PQLAIVTQWCEGSSL 90
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 45.8 bits (107), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 102 TK-PQLAIVTQWCEGSSL 118
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 79 TK-PQLAIVTQWCEGSSL 95
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 44 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 102 TK-PQLAIVTQWCEGSSL 118
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 21 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 79 TK-PQLAIVTQWCEGSSL 95
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 45.8 bits (107), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQE---FINEVASISRTSHVNVVTLLGFC 129
+G G +G VYKGK VAVK+LN + Q+ F NEV + +T HVN++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + A++ ++ SL
Sbjct: 90 TK-PQLAIVTQWCEGSSL 106
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 45.4 bits (106), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/89 (38%), Positives = 45/89 (50%), Gaps = 18/89 (20%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINE--VASISRTSHVNVVTLLGFCL 130
+G+G YG VYKG L D R VAVK+ S N Q FINE + + H N+ +
Sbjct: 21 IGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARFIV--- 74
Query: 131 EGSKRA---------LIYEFMPNGSLEKF 150
G +R L+ E+ PNGSL K+
Sbjct: 75 -GDERVTADGRMEYLLVMEYYPNGSLXKY 102
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGKLSD------GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G D VAVK +N S + EF+NE + + + +VV
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G ++ E M +G L+ +
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSY 110
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGKLSD------GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G D VAVK +N S + EF+NE + + + +VV
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G ++ E M +G L+ +
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSY 110
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGKLSD------GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G D VAVK +N S + EF+NE + + + +VV
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G ++ E M +G L+ +
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSY 110
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGKLSD------GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G D VAVK +N S + EF+NE + + + +VV
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G ++ E M +G L+ +
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSY 110
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGKLSD------GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G D VAVK +N S + EF+NE + + + +VV
Sbjct: 24 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G ++ E M +G L+ +
Sbjct: 84 RLLGVVSKGQPTLVVMELMAHGDLKSY 110
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGKLSD------GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G D VAVK +N S + EF+NE + + + +VV
Sbjct: 21 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G ++ E M +G L+ +
Sbjct: 81 RLLGVVSKGQPTLVVMELMAHGDLKSY 107
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 45.1 bits (105), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGKLSD------GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G D VAVK +N S + EF+NE + + + +VV
Sbjct: 25 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G ++ E M +G L+ +
Sbjct: 85 RLLGVVSKGQPTLVVMELMAHGDLKSY 111
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 44.7 bits (104), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/87 (34%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKGKLSD------GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G D VAVK +N S + EF+NE + + + +VV
Sbjct: 23 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G ++ E M +G L+ +
Sbjct: 83 RLLGVVSKGQPTLVVMELMAHGDLKSY 109
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 44.7 bits (104), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 9/91 (9%)
Query: 69 FKDELGQGGYGRVYKG---KLSD-GRL----VAVKLLNTSKGNGQEFINEVASI-SRTSH 119
F + LGQG + +++KG ++ D G+L V +K+L+ + N E E AS+ S+ SH
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 120 VNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++V G C+ G + L+ EF+ GSL+ +
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 44.7 bits (104), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 9/91 (9%)
Query: 69 FKDELGQGGYGRVYKG---KLSD-GRL----VAVKLLNTSKGNGQEFINEVASI-SRTSH 119
F + LGQG + +++KG ++ D G+L V +K+L+ + N E E AS+ S+ SH
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 120 VNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++V G C G + L+ EF+ GSL+ +
Sbjct: 72 KHLVLNYGVCFCGDENILVQEFVKFGSLDTY 102
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 44.7 bits (104), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 54 PERYSFPNVKKMTNSFKDELGQGGYGRVYKGKLSDGRL---VAVKLLN--TSKGNGQEFI 108
P+ +P + F+D +G+G +G+V K ++ L A+K + SK + ++F
Sbjct: 4 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 63
Query: 109 NEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
E+ + + H N++ LLG C L E+ P+G+L F
Sbjct: 64 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 106
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 44.3 bits (103), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 54 PERYSFPNVKKMTNSFKDELGQGGYGRVYKGKLSDGRL---VAVKLLN--TSKGNGQEFI 108
P+ +P + F+D +G+G +G+V K ++ L A+K + SK + ++F
Sbjct: 14 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 109 NEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
E+ + + H N++ LLG C L E+ P+G+L F
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 44.3 bits (103), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 25/78 (32%), Positives = 44/78 (56%), Gaps = 2/78 (2%)
Query: 73 LGQGGYGRVYKGKLS-DGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
+G G +G VYKGK D + +K+++ + Q F NEVA + +T HVN++ +G+ +
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MT 102
Query: 132 GSKRALIYEFMPNGSLEK 149
A++ ++ SL K
Sbjct: 103 KDNLAIVTQWCEGSSLYK 120
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 44.3 bits (103), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 6/103 (5%)
Query: 54 PERYSFPNVKKMTNSFKDELGQGGYGRVYKGKLSDGRL---VAVKLLN--TSKGNGQEFI 108
P+ +P + F+D +G+G +G+V K ++ L A+K + SK + ++F
Sbjct: 11 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 70
Query: 109 NEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
E+ + + H N++ LLG C L E+ P+G+L F
Sbjct: 71 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 113
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 43.9 bits (102), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 24/76 (31%), Positives = 37/76 (48%)
Query: 72 ELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
ELG G +G V GK VAVK++ + EF E ++ + SH +V G C +
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 132 GSKRALIYEFMPNGSL 147
++ E++ NG L
Sbjct: 75 EYPIYIVTEYISNGCL 90
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 43.9 bits (102), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 73 LGQGGYGRVYKG--KLSDGR--LVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLL 126
+G G +G V G KL R VA+K L + Q +F++E + + + H NV+ L
Sbjct: 41 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 127 GFCLEGSKRALIYEFMPNGSLEKF 150
G + + +I EFM NGSL+ F
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSF 124
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSY 118
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSY 118
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 73 LGQGGYGRVYKG--KLSDGR--LVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLL 126
+G G +G V G KL R VA+K L + Q +F++E + + + H NV+ L
Sbjct: 15 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 127 GFCLEGSKRALIYEFMPNGSLEKF 150
G + + +I EFM NGSL+ F
Sbjct: 75 GVVTKSTPVMIITEFMENGSLDSF 98
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 17 FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI EF+P GSL ++
Sbjct: 77 VKYKGVCYSAGRRNLKLIMEFLPYGSLREY 106
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 25 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 85 RLLGVVSQGQPTLVIMELMTRGDLKSY 111
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 17 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 77 RLLGVVSQGQPTLVIMELMTRGDLKSY 103
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 23 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 83 RLLGVVSQGQPTLVIMELMTRGDLKSY 109
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 22 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 82 RLLGVVSQGQPTLVIMELMTRGDLKSY 108
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 43.5 bits (101), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 25 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 85 RLLGVVSQGQPTLVIMELMTRGDLKSY 111
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 43.5 bits (101), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 26 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 86 RLLGVVSQGQPTLVIMELMTRGDLKSY 112
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 43.5 bits (101), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 19 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 79 RLLGVVSQGQPTLVIMELMTRGDLKSY 105
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 43.5 bits (101), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 26 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 86 RLLGVVSQGQPTLVIMELMTRGDLKSY 112
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 43.5 bits (101), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 72 ELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVV 123
ELGQG +G VY+G K VA+K +N + + EF+NE + + + +VV
Sbjct: 19 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 124 TLLGFCLEGSKRALIYEFMPNGSLEKF 150
LLG +G +I E M G L+ +
Sbjct: 79 RLLGVVSQGQPTLVIMELMTRGDLKSY 105
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 42.7 bits (99), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 24/83 (28%), Positives = 43/83 (51%), Gaps = 3/83 (3%)
Query: 71 DELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNG--QEFINEVASISRTSHVNVVTLLG 127
+++G+G +G V+ G+L +D LVAVK + +F+ E + + SH N+V L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
C + ++ E + G F
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTF 202
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 42.7 bits (99), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 24/83 (28%), Positives = 43/83 (51%), Gaps = 3/83 (3%)
Query: 71 DELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNG--QEFINEVASISRTSHVNVVTLLG 127
+++G+G +G V+ G+L +D LVAVK + +F+ E + + SH N+V L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
C + ++ E + G F
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTF 202
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 42.7 bits (99), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 18 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 78 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 107
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 42.7 bits (99), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 13 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 73 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 102
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 42.4 bits (98), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 103
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 42.4 bits (98), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 12 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 72 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 101
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 42.4 bits (98), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 18/97 (18%)
Query: 58 SFPNVKKMTNSFKDE-------------LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNG 104
SFP T+ F E +G+G +G+VY G+ VA++L++ + N
Sbjct: 13 SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNE 70
Query: 105 QE---FINEVASISRTSHVNVVTLLGFCLEGSKRALI 138
+ F EV + +T H NVV +G C+ A+I
Sbjct: 71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 42.4 bits (98), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 19 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 79 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 108
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 42.4 bits (98), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 17 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 77 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 106
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 42.4 bits (98), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 17 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 77 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 106
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 20 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 80 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 109
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 134
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 103
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 21 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 81 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 110
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 32 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 92 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 121
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 15 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 75 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 104
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 103
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 42.4 bits (98), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)
Query: 69 FKDELGQGGYGRVYKGK---LSD--GRLVAVK-LLNTSKGNGQEFINEVASISRTSHVNV 122
F +LG+G +G V + L D G +VAVK L ++++ + ++F E+ + H N+
Sbjct: 32 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 123 VTLLGFCLEGSKR--ALIYEFMPNGSLEKF 150
V G C +R LI E++P GSL +
Sbjct: 92 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 121
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 42.0 bits (97), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLL--NTSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + DG VA+K+L NTS +E ++E ++ V L
Sbjct: 25 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + L+ + MP G L
Sbjct: 85 LGICLTSTVQ-LVTQLMPYGCL 105
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 4/78 (5%)
Query: 70 KDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFC 129
++ +G+G +G V K K + VA+K + S+ + FI E+ +SR +H N+V L G C
Sbjct: 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 130 LEGSKRALIYEFMPNGSL 147
L + L+ E+ GSL
Sbjct: 71 L--NPVCLVMEYAEGGSL 86
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 13 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 72 LDVIHTENKLYLVFEFL-HQDLKKF 95
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 44/78 (56%), Gaps = 4/78 (5%)
Query: 70 KDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFC 129
++ +G+G +G V K K + VA+K + S+ + FI E+ +SR +H N+V L G C
Sbjct: 14 EEVVGRGAFGVVCKAKWR-AKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 130 LEGSKRALIYEFMPNGSL 147
L + L+ E+ GSL
Sbjct: 72 L--NPVCLVMEYAEGGSL 87
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/112 (25%), Positives = 56/112 (50%), Gaps = 10/112 (8%)
Query: 38 SDQDLEAFIRNYVSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYKG-KLSDGRLVAVKL 96
SD+++ +R+ VS+ + + +K +GQG G VY ++ G+ VA++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQ 52
Query: 97 LNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
+N + +E I NE+ + + N+V L L G + ++ E++ GSL
Sbjct: 53 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/112 (25%), Positives = 56/112 (50%), Gaps = 10/112 (8%)
Query: 38 SDQDLEAFIRNYVSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYKG-KLSDGRLVAVKL 96
SD+++ +R+ VS+ + + +K +GQG G VY ++ G+ VA++
Sbjct: 2 SDEEILEKLRSIVSVGDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQ 53
Query: 97 LNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
+N + +E I NE+ + + N+V L L G + ++ E++ GSL
Sbjct: 54 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 105
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/112 (25%), Positives = 56/112 (50%), Gaps = 10/112 (8%)
Query: 38 SDQDLEAFIRNYVSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYKG-KLSDGRLVAVKL 96
SD+++ +R+ VS+ + + +K +GQG G VY ++ G+ VA++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQ 52
Query: 97 LNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
+N + +E I NE+ + + N+V L L G + ++ E++ GSL
Sbjct: 53 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 41.6 bits (96), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 67 LDVIHTENKLYLVFEFL-HQDLKKF 90
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 67 LDVIHTENKLYLVFEFL-HQDLKKF 90
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 16 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 75 LDVIHTENKLYLVFEFL-HQDLKKF 98
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 67 LDVIHTENKLYLVFEFL-HQDLKKF 90
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 67 LDVIHTENKLYLVFEFL-HQDLKKF 90
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/112 (25%), Positives = 56/112 (50%), Gaps = 10/112 (8%)
Query: 38 SDQDLEAFIRNYVSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYKG-KLSDGRLVAVKL 96
SD+++ +R+ VS+ + + +K +GQG G VY ++ G+ VA++
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQ 52
Query: 97 LNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
+N + +E I NE+ + + N+V L L G + ++ E++ GSL
Sbjct: 53 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 11 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 70 LDVIHTENKLYLVFEFL-HQDLKKF 93
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 11 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 70 LDVIHTENKLYLVFEFL-HQDLKKF 93
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVA---VKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA ++L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVA---VKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA ++L ++G I E++ + +H N+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLT-GEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 67 LDVIHTENKLYLVFEFL-HQDLKKF 90
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 16 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 75 LDVIHTENKLYLVFEFL-HQDLKKF 98
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 12 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 71 LDVIHTENKLYLVFEFL-HQDLKKF 94
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 11 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 70 LDVIHTENKLYLVFEFL-HQDLKKF 93
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 10 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 69 LDVIHTENKLYLVFEFL-HQDLKKF 92
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 10 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 69 LDVIHTENKLYLVFEFL-HQDLKKF 92
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/76 (36%), Positives = 40/76 (52%), Gaps = 5/76 (6%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK--LLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
D+LG+G Y VYKG KL+D LVA+K L +G I EV+ + H N+VTL
Sbjct: 8 DKLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 127 GFCLEGSKRALIYEFM 142
L++E++
Sbjct: 67 DIIHTEKSLTLVFEYL 82
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 10 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 69 LDVIHTENKLYLVFEFL-HQDLKKF 92
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 10 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 69 LDVIHTENKLYLVFEFL-HQDLKKF 92
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 68 LDVIHTENKLYLVFEFL-HQDLKKF 91
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 13 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 72 LDVIHTENKLYLVFEFL-HQDLKKF 95
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 12 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 71 LDVIHTENKLYLVFEFL-HQDLKKF 94
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 69 FKDELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKG-----NGQEFINEVASISRTSHVNV 122
++ +G G +G V +G+L + G+ + + T KG +EF++E + + + H N+
Sbjct: 18 IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ L G ++ EFM NG+L+ F
Sbjct: 78 IRLEGVVTNSMPVMILTEFMENGALDSF 105
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 41.2 bits (95), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 69 FKDELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKG-----NGQEFINEVASISRTSHVNV 122
++ +G G +G V +G+L + G+ + + T KG +EF++E + + + H N+
Sbjct: 20 IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ L G ++ EFM NG+L+ F
Sbjct: 80 IRLEGVVTNSMPVMILTEFMENGALDSF 107
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 40.8 bits (94), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 4/83 (4%)
Query: 71 DELGQGGYGRVYKG-KLSDGRLVAVK--LLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
++LG G Y VYKG + G VA+K L++ +G I E++ + H N+V L
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
+K L++EFM N L+K+
Sbjct: 71 VIHTENKLTLVFEFMDN-DLKKY 92
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 40.8 bits (94), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 36/79 (45%)
Query: 72 ELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
+LG G +G V+ G ++ VAVK L + Q F+ E + H +V L +
Sbjct: 19 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 132 GSKRALIYEFMPNGSLEKF 150
+I EFM GSL F
Sbjct: 79 EEPIYIITEFMAKGSLLDF 97
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 40.8 bits (94), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 12 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 71 LDVIHTENKLYLVFEFL-SMDLKKF 94
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 40.8 bits (94), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 10 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++EF+ + L+KF
Sbjct: 69 LDVIHTENKLYLVFEFL-SMDLKKF 92
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 40.8 bits (94), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 18/118 (15%)
Query: 48 NYVSLAP------ERYSFPNVKKMTNSFKDELGQGGYGRVYKGKL-----SDGRL-VAVK 95
NYV + P ++ FP + SF LG G +G+V + SD + VAVK
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRL---SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 59
Query: 96 LLNTSKG--NGQEFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+L S + ++E+ +S +H+N+V LLG C G +I E+ G L F
Sbjct: 60 MLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 40.4 bits (93), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 18/118 (15%)
Query: 48 NYVSLAP------ERYSFPNVKKMTNSFKDELGQGGYGRVYKGKL-----SDGRL-VAVK 95
NYV + P ++ FP + SF LG G +G+V + SD + VAVK
Sbjct: 21 NYVYIDPTQLPYDHKWEFPRNRL---SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 77
Query: 96 LLNTSKG--NGQEFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+L S + ++E+ +S +H+N+V LLG C G +I E+ G L F
Sbjct: 78 MLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 135
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 40.4 bits (93), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 72 ELGQGGYGRVYKGKLSD-----GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVT 124
+LG+G +G+V + G VAVK L G + E+ + H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 125 LLGFCLE--GSKRALIYEFMPNGSLEKF 150
G C E G+ LI EF+P+GSL+++
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEY 115
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 40.4 bits (93), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 72 ELGQGGYGRVYKGKLSD-----GRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVT 124
+LG+G +G+V + G VAVK L G + E+ + H N+V
Sbjct: 16 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 75
Query: 125 LLGFCLE--GSKRALIYEFMPNGSLEKF 150
G C E G+ LI EF+P+GSL+++
Sbjct: 76 YKGICTEDGGNGIKLIMEFLPSGSLKEY 103
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 40.4 bits (93), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 18/118 (15%)
Query: 48 NYVSLAP------ERYSFPNVKKMTNSFKDELGQGGYGRVYKGKL-----SDGRL-VAVK 95
NYV + P ++ FP + SF LG G +G+V + SD + VAVK
Sbjct: 26 NYVYIDPTQLPYDHKWEFPRNRL---SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 82
Query: 96 LLNTSKG--NGQEFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+L S + ++E+ +S +H+N+V LLG C G +I E+ G L F
Sbjct: 83 MLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 140
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 40.4 bits (93), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 27 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 87 LGICLTSTVQ-LIMQLMPFGCL 107
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 40.4 bits (93), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 18/118 (15%)
Query: 48 NYVSLAP------ERYSFPNVKKMTNSFKDELGQGGYGRVYKGKL-----SDGRL-VAVK 95
NYV + P ++ FP + SF LG G +G+V + SD + VAVK
Sbjct: 26 NYVYIDPTQLPYDHKWEFPRNRL---SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 82
Query: 96 LLNTSKG--NGQEFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+L S + ++E+ +S +H+N+V LLG C G +I E+ G L F
Sbjct: 83 MLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 140
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 40.4 bits (93), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 84 LGICLTSTVQ-LIMQLMPFGXL 104
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 40.4 bits (93), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 83 LGICLTSTVQ-LIMQLMPFGCL 103
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 40.4 bits (93), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 84 LGICLTSTVQ-LIMQLMPFGCL 104
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 40.4 bits (93), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 27 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 87 LGICLTSTVQ-LIMQLMPFGCL 107
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 40.0 bits (92), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 85 LGICLTSTVQ-LIMQLMPFGCL 105
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 40.0 bits (92), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 85 LGICLTSTVQ-LIMQLMPFGCL 105
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 40.0 bits (92), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 86 LGICLTSTVQ-LIMQLMPFGCL 106
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 85 LGICLTSTVQ-LIMQLMPFGCL 105
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 73 LGQGGYGRVYKGKLS-DGR---LVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLL 126
+G G +G V G+L G+ VA+K L + Q +F++E + + + H N++ L
Sbjct: 16 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 127 GFCLEGSKRALIYEFMPNGSLEKF 150
G + +I E+M NGSL+ F
Sbjct: 76 GVVTKCKPVMIITEYMENGSLDAF 99
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 73 LGQGGYGRVYKGKLS-DGR---LVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLL 126
+G G +G V G+L G+ VA+K L + Q +F++E + + + H N++ L
Sbjct: 37 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 127 GFCLEGSKRALIYEFMPNGSLEKF 150
G + +I E+M NGSL+ F
Sbjct: 97 GVVTKCKPVMIITEYMENGSLDAF 120
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 33 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 93 LGICLTSTVQ-LITQLMPFGCL 113
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 34/122 (27%), Positives = 53/122 (43%), Gaps = 21/122 (17%)
Query: 46 IRNYVSLAPERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL 91
+R YV P Y P + + F EL G G +G V G+L S +
Sbjct: 17 LRTYVD--PHTYEDPT--QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 72
Query: 92 -VAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLE 148
VA+K L Q +F+ E + + + H N++ L G + ++ E+M NGSL+
Sbjct: 73 SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 132
Query: 149 KF 150
F
Sbjct: 133 SF 134
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 32/122 (26%), Positives = 55/122 (45%), Gaps = 21/122 (17%)
Query: 46 IRNYVSLAPERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL 91
+R YV + ++F + + + F EL G G +G V G+L S +
Sbjct: 19 LRTYV----DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 92 -VAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLE 148
VA+K L Q +F+ E + + + H N++ L G + ++ E+M NGSL+
Sbjct: 75 SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 149 KF 150
F
Sbjct: 135 SF 136
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/112 (25%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 38 SDQDLEAFIRNYVSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYKG-KLSDGRLVAVKL 96
SD+++ +R VS+ + + +K +GQG G VY ++ G+ VA++
Sbjct: 2 SDEEILEKLRIIVSVGDPKKKYTRFEK--------IGQGASGTVYTAMDVATGQEVAIRQ 53
Query: 97 LNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
+N + +E I NE+ + + N+V L L G + ++ E++ GSL
Sbjct: 54 MNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 105
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 83 LGICLTSTVQ-LITQLMPFGXL 103
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/84 (30%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 73 LGQGGYGRVYKGKLS-DGR---LVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLL 126
+G G +G V G+L G+ VA+K L + Q +F++E + + + H N++ L
Sbjct: 22 IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 127 GFCLEGSKRALIYEFMPNGSLEKF 150
G + +I E+M NGSL+ F
Sbjct: 82 GVVTKCKPVMIITEYMENGSLDAF 105
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 77 LGICLTSTVQ-LITQLMPFGCL 97
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCL 103
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 6/77 (7%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 11 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 126 LGFCLEGSKRALIYEFM 142
L +K L++EF+
Sbjct: 70 LDVIHTENKLYLVFEFL 86
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCL 103
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 40.0 bits (92), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 34/122 (27%), Positives = 53/122 (43%), Gaps = 21/122 (17%)
Query: 46 IRNYVSLAPERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL 91
+R YV P Y P + + F EL G G +G V G+L S +
Sbjct: 19 LRTYVD--PHTYEDPT--QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 92 -VAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLE 148
VA+K L Q +F+ E + + + H N++ L G + ++ E+M NGSL+
Sbjct: 75 SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134
Query: 149 KF 150
F
Sbjct: 135 SF 136
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 40.0 bits (92), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 6/77 (7%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 9 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 126 LGFCLEGSKRALIYEFM 142
L +K L++EF+
Sbjct: 68 LDVIHTENKLYLVFEFL 84
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 40.0 bits (92), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 86 LGICLTSTVQ-LITQLMPFGCL 106
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 40.0 bits (92), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 6/77 (7%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 12 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 126 LGFCLEGSKRALIYEFM 142
L +K L++EF+
Sbjct: 71 LDVIHTENKLYLVFEFL 87
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 40.0 bits (92), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 20 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 80 LGICLTSTVQ-LITQLMPFGCL 100
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 85 LGICLTSTVQ-LITQLMPFGCL 105
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 86 LGICLTSTVQ-LITQLMPFGCL 106
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 85 LGICLTSTVQ-LITQLMPFGCL 105
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 86 LGICLTSTVQ-LITQLMPFGCL 106
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 48 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCL 128
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 29 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 89 LGICLTSTVQ-LITQLMPFGCL 109
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCL 103
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 6/77 (7%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 12 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 126 LGFCLEGSKRALIYEFM 142
L +K L++EF+
Sbjct: 71 LDVIHTENKLYLVFEFL 87
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 30 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 90 LGICLTSTVQ-LITQLMPFGCL 110
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 39.7 bits (91), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 29/82 (35%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 30 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 90 LGICLTSTVQ-LITQLMPFGCL 110
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 39.7 bits (91), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/132 (22%), Positives = 61/132 (46%), Gaps = 14/132 (10%)
Query: 30 VCCRKATKSDQDLEAFIRNYVSLAPERYSFPNVKKMTNSFKDELGQGGYGRVY------- 82
+ R ++ +D + A + Y ++ FP K + LG+G +G+V
Sbjct: 49 ITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKL---TLGKPLGEGCFGQVVMAEAVGI 105
Query: 83 -KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVNVVTLLGFCLEGSKRALI 138
K K + VAVK+L + ++ + + ++E+ + H N++ LLG C + +I
Sbjct: 106 DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165
Query: 139 YEFMPNGSLEKF 150
E+ G+L ++
Sbjct: 166 VEYASKGNLREY 177
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 39.7 bits (91), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 30/103 (29%), Positives = 52/103 (50%), Gaps = 6/103 (5%)
Query: 50 VSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYKGKLSD-GRLVAVKLL---NTSKGNGQ 105
V L E F +++K N +G+G YG V K + D GR+VA+K + K +
Sbjct: 12 VDLGTENLYFQSMEKYENL--GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69
Query: 106 EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLE 148
+ E+ + + H N+V LL C + + L++EF+ + L+
Sbjct: 70 IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILD 112
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 39.7 bits (91), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LG G +G V+ G ++ VAVK L + Q F+ E + H +V L
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTRE 80
Query: 133 SKRALIYEFMPNGSLEKF 150
+I E+M GSL F
Sbjct: 81 EPIYIITEYMAKGSLLDF 98
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 39.3 bits (90), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 15/113 (13%)
Query: 50 VSLAPERYSFPNVKKMTNSFKD-----------ELGQGGYGRVYKGKLSDGR-LVAVKLL 97
V L E F ++K+ + +D ELG G +G+VYK + + L A K++
Sbjct: 11 VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 98 NT-SKGNGQEFINEVASISRTSHVNVVTLL-GFCLEGSKRALIYEFMPNGSLE 148
+T S+ ++++ E+ ++ H N+V LL F E + LI EF G+++
Sbjct: 71 DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVD 122
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 39.3 bits (90), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 15/113 (13%)
Query: 50 VSLAPERYSFPNVKKMTNSFKD-----------ELGQGGYGRVYKGKLSDGR-LVAVKLL 97
V L E F ++K+ + +D ELG G +G+VYK + + L A K++
Sbjct: 11 VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 98 NT-SKGNGQEFINEVASISRTSHVNVVTLL-GFCLEGSKRALIYEFMPNGSLE 148
+T S+ ++++ E+ ++ H N+V LL F E + LI EF G+++
Sbjct: 71 DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVD 122
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 39.3 bits (90), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 31/114 (27%), Positives = 50/114 (43%), Gaps = 19/114 (16%)
Query: 54 PERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKLS-DGR---LVAVKLLN 98
P Y PN + + F E+ G G +G V G+L G+ VA+K L
Sbjct: 2 PHTYEDPN--QAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLK 59
Query: 99 TSKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
Q +F+ E + + + H N++ L G + ++ E+M NGSL+ F
Sbjct: 60 VGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTF 113
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 39.3 bits (90), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 15/113 (13%)
Query: 50 VSLAPERYSFPNVKKMTNSFKD-----------ELGQGGYGRVYKGKLSDGR-LVAVKLL 97
V L E F ++K+ + +D ELG G +G+VYK + + L A K++
Sbjct: 11 VDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI 70
Query: 98 NT-SKGNGQEFINEVASISRTSHVNVVTLL-GFCLEGSKRALIYEFMPNGSLE 148
+T S+ ++++ E+ ++ H N+V LL F E + LI EF G+++
Sbjct: 71 DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVD 122
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 39.3 bits (90), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 74
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 75 EPIXIVTEYMSKGSLLDF 92
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++TLLG C + +I E+ G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREY 131
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 38.9 bits (89), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLL------NTSKGNGQEFINEVASISRTSHVNVVTL 125
LG G +G VYKG + +G V + + TS +E ++E ++ + +V L
Sbjct: 57 LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCL 137
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 38.9 bits (89), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 85 EPIYIVIEYMSKGSLLDF 102
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 38.9 bits (89), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE- 84
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 85 EPIYIVTEYMSKGSLLDF 102
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 38.9 bits (89), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 85 EPIYIVIEYMSKGSLLDF 102
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 38.9 bits (89), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 73
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 74 EPIYIVTEYMSKGSLLDF 91
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 38.9 bits (89), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 77
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 78 EPIYIVTEYMSKGSLLDF 95
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 75
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 76 EPIYIVTEYMSKGSLLDF 93
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/118 (27%), Positives = 53/118 (44%), Gaps = 9/118 (7%)
Query: 42 LEAFIRNYVSLAPER--YSFPNVKKMTN-SFKDELGQGGYGRVYKGKL---SDGRL-VAV 94
L F+ + P + + F TN S +G G +G V G+L S + VA+
Sbjct: 19 LRTFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 95 KLLNTSKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
K L Q +F+ E + + + H N++ L G + ++ E+M NGSL+ F
Sbjct: 79 KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 51/113 (45%), Gaps = 17/113 (15%)
Query: 55 ERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL-VAVKLLNT 99
+ ++F + + + F EL G G +G V G+L S + VA+K L
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 100 SKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
Q +F+ E + + + H N++ L G + ++ E+M NGSL+ F
Sbjct: 84 GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 51/113 (45%), Gaps = 17/113 (15%)
Query: 55 ERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL-VAVKLLNT 99
+ ++F + + + F EL G G +G V G+L S + VA+K L
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 100 SKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
Q +F+ E + + + H N++ L G + ++ E+M NGSL+ F
Sbjct: 84 GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 51/113 (45%), Gaps = 17/113 (15%)
Query: 55 ERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL-VAVKLLNT 99
+ ++F + + + F EL G G +G V G+L S + VA+K L
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 100 SKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
Q +F+ E + + + H N++ L G + ++ E+M NGSL+ F
Sbjct: 84 GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 51/113 (45%), Gaps = 17/113 (15%)
Query: 55 ERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL-VAVKLLNT 99
+ ++F + + + F EL G G +G V G+L S + VA+K L
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 100 SKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
Q +F+ E + + + H N++ L G + ++ E+M NGSL+ F
Sbjct: 84 GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFC 129
++G+G G V + S G+LVAVK ++ K +E + NEV + H NVV +
Sbjct: 27 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 130 LEGSKRALIYEFMPNGSL 147
L G + ++ EF+ G+L
Sbjct: 87 LVGDELWVVMEFLEGGAL 104
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 85 EPIYIVTEYMSKGSLLDF 102
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 85 EPIYIVTEYMSKGSLLDF 102
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFC 129
++G+G G V + S G+LVAVK ++ K +E + NEV + H NVV +
Sbjct: 36 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 130 LEGSKRALIYEFMPNGSL 147
L G + ++ EF+ G+L
Sbjct: 96 LVGDELWVVMEFLEGGAL 113
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLSD--GR----LVAVKLL--NTSKGNGQEFINEVASISRTSHVNVVT 124
LG+G +G+V K GR VAVK+L N S ++ ++E + + +H +V+
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
L G C + LI E+ GSL F
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGF 116
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLSD--GR----LVAVKLL--NTSKGNGQEFINEVASISRTSHVNVVT 124
LG+G +G+V K GR VAVK+L N S ++ ++E + + +H +V+
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
L G C + LI E+ GSL F
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGF 116
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFC 129
++G+G G V + S G+LVAVK ++ K +E + NEV + H NVV +
Sbjct: 31 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 130 LEGSKRALIYEFMPNGSL 147
L G + ++ EF+ G+L
Sbjct: 91 LVGDELWVVMEFLEGGAL 108
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 38.5 bits (88), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 8/86 (9%)
Query: 73 LGQGGYGRVYKGKLSD--GR----LVAVKLL--NTSKGNGQEFINEVASISRTSHVNVVT 124
LG+G +G+V K GR VAVK+L N S ++ ++E + + +H +V+
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCLEGSKRALIYEFMPNGSLEKF 150
L G C + LI E+ GSL F
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGF 116
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 38.5 bits (88), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 251 EPIYIVTEYMSKGSLLDF 268
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 38.5 bits (88), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 6/89 (6%)
Query: 68 SFKDELGQGGYGRVYKGKL---SDGRL-VAVKLLNTSKGNGQ--EFINEVASISRTSHVN 121
S +G G +G V G+L S + VA+K L Q +F+ E + + + H N
Sbjct: 19 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ L G + ++ E+M NGSL+ F
Sbjct: 79 IIRLEGVVTKSKPVMIVTEYMENGSLDSF 107
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 38.5 bits (88), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 251 EPIYIVTEYMSKGSLLDF 268
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 38.5 bits (88), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 85 EPIYIVCEYMSKGSLLDF 102
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 38.5 bits (88), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFC 129
++G+G G V + S G+LVAVK ++ K +E + NEV + H NVV +
Sbjct: 38 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 130 LEGSKRALIYEFMPNGSL 147
L G + ++ EF+ G+L
Sbjct: 98 LVGDELWVVMEFLEGGAL 115
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 38.5 bits (88), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 55 ERYSFPNVKKMTNSFKDELGQGGYGRVYK------GKLSDGRLVAVKLL-NTSKGNGQE- 106
E++ FP + F LG G +G+V + GK VAVK+L +T+ + +E
Sbjct: 31 EKWEFP---RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA 87
Query: 107 FINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++E+ +S H N+V LLG C G +I E+ G L F
Sbjct: 88 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 132
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 38.5 bits (88), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 1/79 (1%)
Query: 72 ELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
+LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 132 GSKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 252 -EPIYIVTEYMSKGSLLDF 269
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 6/89 (6%)
Query: 68 SFKDELGQGGYGRVYKGKL---SDGRL-VAVKLLNTSKGNGQ--EFINEVASISRTSHVN 121
S +G G +G V G+L S + VA+K L Q +F+ E + + + H N
Sbjct: 36 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 95
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ L G + ++ E+M NGSL+ F
Sbjct: 96 IIRLEGVVTKSKPVMIVTEYMENGSLDSF 124
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 55 ERYSFPNVKKMTNSFKDELGQGGYGRVYKGKL-----SDGRL-VAVKLLNTSKG--NGQE 106
++ FP + SF LG G +G+V + SD + VAVK+L S +
Sbjct: 32 HKWEFPRNRL---SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 88
Query: 107 FINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++E+ +S +H+N+V LLG C G +I E+ G L F
Sbjct: 89 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 133
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFC 129
++G+G G V + S G+LVAVK ++ K +E + NEV + H NVV +
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 130 LEGSKRALIYEFMPNGSL 147
L G + ++ EF+ G+L
Sbjct: 218 LVGDELWVVMEFLEGGAL 235
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 55 ERYSFPNVKKMTNSFKDELGQGGYGRVYK------GKLSDGRLVAVKLL-NTSKGNGQE- 106
E++ FP + F LG G +G+V + GK VAVK+L +T+ + +E
Sbjct: 39 EKWEFP---RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA 95
Query: 107 FINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++E+ +S H N+V LLG C G +I E+ G L F
Sbjct: 96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 55 ERYSFPNVKKMTNSFKDELGQGGYGRVYK------GKLSDGRLVAVKLL-NTSKGNGQE- 106
E++ FP + F LG G +G+V + GK VAVK+L +T+ + +E
Sbjct: 24 EKWEFP---RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA 80
Query: 107 FINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++E+ +S H N+V LLG C G +I E+ G L F
Sbjct: 81 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 125
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 55 ERYSFPNVKKMTNSFKDELGQGGYGRVYK------GKLSDGRLVAVKLL-NTSKGNGQE- 106
E++ FP + F LG G +G+V + GK VAVK+L +T+ + +E
Sbjct: 39 EKWEFP---RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA 95
Query: 107 FINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++E+ +S H N+V LLG C G +I E+ G L F
Sbjct: 96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 34/122 (27%), Positives = 52/122 (42%), Gaps = 21/122 (17%)
Query: 46 IRNYVSLAPERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL 91
+R YV P Y P + + F EL G G +G V G+L S +
Sbjct: 19 LRTYVD--PHTYEDPT--QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74
Query: 92 -VAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLE 148
VA+K L Q +F+ E + + + H N++ L G + ++ E M NGSL+
Sbjct: 75 SVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD 134
Query: 149 KF 150
F
Sbjct: 135 SF 136
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 81
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 82 EPIYIVTEYMNKGSLLDF 99
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 6/84 (7%)
Query: 73 LGQGGYGRVYKGKL----SDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLL 126
+G G G V G+L VA+K L Q +F++E + + + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 127 GFCLEGSKRALIYEFMPNGSLEKF 150
G G ++ E+M NGSL+ F
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTF 140
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 7/85 (8%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 12 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
L +K L++E + + L+KF
Sbjct: 71 LDVIHTENKLYLVFEHV-DQDLKKF 94
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 6/84 (7%)
Query: 73 LGQGGYGRVYKGKL----SDGRLVAVKLLNTSKGNGQ--EFINEVASISRTSHVNVVTLL 126
+G G G V G+L VA+K L Q +F++E + + + H N++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 127 GFCLEGSKRALIYEFMPNGSLEKF 150
G G ++ E+M NGSL+ F
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTF 140
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 1/79 (1%)
Query: 72 ELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
+LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 132 GSKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 334 -EPIYIVTEYMSKGSLLDF 351
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 24/83 (28%), Positives = 44/83 (53%), Gaps = 8/83 (9%)
Query: 73 LGQGGYGRVYKGK-LSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV-NVVTLLGFCL 130
+G G YG+VYKG+ + G+L A+K+++ + +E E+ + + SH N+ T G +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 131 E------GSKRALIYEFMPNGSL 147
+ + L+ EF GS+
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSV 114
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 42/78 (53%), Gaps = 2/78 (2%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFC 129
++G+G G V + S G+LVAVK ++ K +E + NEV + H NVV +
Sbjct: 81 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 130 LEGSKRALIYEFMPNGSL 147
L G + ++ EF+ G+L
Sbjct: 141 LVGDELWVVMEFLEGGAL 158
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 81
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 82 EPIYIVTEYMNKGSLLDF 99
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 55 ERYSFPNVKKMTNSFKDELGQGGYGRVYK------GKLSDGRLVAVKLL-NTSKGNGQE- 106
E++ FP + F LG G +G+V + GK VAVK+L +T+ + +E
Sbjct: 39 EKWEFP---RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA 95
Query: 107 FINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++E+ +S H N+V LLG C G +I E+ G L F
Sbjct: 96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 55 ERYSFPNVKKMTNSFKDELGQGGYGRVYK------GKLSDGRLVAVKLL-NTSKGNGQE- 106
E++ FP + F LG G +G+V + GK VAVK+L +T+ + +E
Sbjct: 39 EKWEFP---RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA 95
Query: 107 FINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++E+ +S H N+V LLG C G +I E+ G L F
Sbjct: 96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 38.1 bits (87), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 43/91 (47%), Gaps = 13/91 (14%)
Query: 73 LGQGGYGRVYKGKL--SDGRLV--AVKLLNT---SKGNGQEFINEVASISRTSHVNVVTL 125
LG+G +G V + +L DG V AVK+L + + +EF+ E A + H +V L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 126 LGFCLEGSKRA------LIYEFMPNGSLEKF 150
+G L + +I FM +G L F
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 37.7 bits (86), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
L G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 30 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 90 LGICLTSTVQ-LIMQLMPFGCL 110
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 37.7 bits (86), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
L G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 23 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCL 103
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 37.7 bits (86), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 251 EPIYIVGEYMSKGSLLDF 268
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 18 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 77
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 78 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 106
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 73 LGQGGYGRVYKGKLSDGRLV-AVKLLNTSK----GNGQEFINEVASISRTSHVNVVTLLG 127
LG+G +G VY + + + A+K+L ++ G + EV S H N++ L G
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCLEGSKRALIYEFMPNGSLEK 149
+ + ++ LI E+ P G + K
Sbjct: 81 YFHDATRVYLILEYAPRGEVYK 102
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 73 LGQGGYGRVYKGKLSDGR----LVAVKLL--NTSKGNGQEFINEVASISRTSHVNVVTLL 126
LG+G +G VY+G ++ + VAVK + + N ++F++E + H ++V L+
Sbjct: 16 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G +E +I E P G L
Sbjct: 76 GI-IEEEPTWIIMELYPYGEL 95
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 15 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 75 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 103
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 73 LGQGGYGRVYKGKLSDGRLV-AVKLLNTSK----GNGQEFINEVASISRTSHVNVVTLLG 127
LG+G +G VY + + + A+K+L ++ G + EV S H N++ L G
Sbjct: 21 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCLEGSKRALIYEFMPNGSLEK 149
+ + ++ LI E+ P G + K
Sbjct: 81 YFHDATRVYLILEYAPRGEVYK 102
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 10/105 (9%)
Query: 50 VSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYKG-KLSDGRLVAVK---LLNTSKGNGQ 105
VS AP S +++T +LG+G YG VYK VA+K L + +G
Sbjct: 24 VSAAPSATSIDRYRRIT-----KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG 78
Query: 106 EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
I EV+ + H N++ L + LI+E+ N L+K+
Sbjct: 79 TAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKY 122
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 15 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 74
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 75 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 103
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 8/82 (9%)
Query: 73 LGQGGYGRVYKG-KLSDGR----LVAVKLLN--TSKGNGQEFINEVASISRTSHVNVVTL 125
L G +G VYKG + +G VA+K L TS +E ++E ++ + +V L
Sbjct: 30 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
LG CL + + LI + MP G L
Sbjct: 90 LGICLTSTVQ-LITQLMPFGCL 110
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 11 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 70
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 71 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 99
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 14 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 73
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 74 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 102
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 10 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 69
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 70 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 98
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 19 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 78
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 79 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 107
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 17 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 76
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 77 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 105
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 2/78 (2%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFC 129
++G+G G V + GR VAVK+++ K +E + NEV + H NVV +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 130 LEGSKRALIYEFMPNGSL 147
L G + ++ EF+ G+L
Sbjct: 112 LVGEELWVLMEFLQGGAL 129
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 37.4 bits (85), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 24/84 (28%), Positives = 40/84 (47%), Gaps = 4/84 (4%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVA--VKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+F +L + G ++KG+ +V +K+ + S ++F E + SH NV+ +
Sbjct: 13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 126 LGFC--LEGSKRALIYEFMPNGSL 147
LG C LI +MP GSL
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSL 96
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 37.4 bits (85), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 39/89 (43%), Gaps = 1/89 (1%)
Query: 62 VKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVN 121
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 6 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR 65
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 66 LVRLYAVVTQ-EPIYIITEYMENGSLVDF 93
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 37.4 bits (85), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G +G V+ G + VAVK L + F+ E + + H
Sbjct: 4 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 63
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 64 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 92
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 37.4 bits (85), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M G L F
Sbjct: 85 EPIYIVMEYMSKGCLLDF 102
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 73 LGQGGYGRVYKGKLSDGR----LVAVKLL--NTSKGNGQEFINEVASISRTSHVNVVTLL 126
LG+G +G VY+G ++ + VAVK + + N ++F++E + H ++V L+
Sbjct: 32 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G +E +I E P G L
Sbjct: 92 GI-IEEEPTWIIMELYPYGEL 111
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 73 LGQGGYGRVYKGKLSDGR----LVAVKLL--NTSKGNGQEFINEVASISRTSHVNVVTLL 126
LG+G +G VY+G ++ + VAVK + + N ++F++E + H ++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G +E +I E P G L
Sbjct: 80 GI-IEEEPTWIIMELYPYGEL 99
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I E+ G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I E+ G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I E+ G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 17/113 (15%)
Query: 55 ERYSFPNVKKMTNSFKDEL-----------GQGGYGRVYKGKL---SDGRL-VAVKLLNT 99
+ ++F + + + F EL G G +G V G+L S + VA+K L
Sbjct: 24 DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 83
Query: 100 SKGNGQ--EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
Q +F+ E + + + H N++ L G + ++ E M NGSL+ F
Sbjct: 84 GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I E+ G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I E+ G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCL-E 131
+G+G +G V G G VAVK + + Q F+ E + +++ H N+V LLG + E
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 132 GSKRALIYEFMPNGSLEKF 150
++ E+M GSL +
Sbjct: 259 KGGLYIVTEYMAKGSLVDY 277
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 37.0 bits (84), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LGQG +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 84
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M G L F
Sbjct: 85 EPIYIVTEYMSKGCLLDF 102
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 37.0 bits (84), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCL-E 131
+G+G +G V G G VAVK + Q F+ E + +++ H N+V LLG + E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 132 GSKRALIYEFMPNGSLEKF 150
++ E+M GSL +
Sbjct: 72 KGGLYIVTEYMAKGSLVDY 90
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 36.6 bits (83), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 25/77 (32%), Positives = 43/77 (55%), Gaps = 6/77 (7%)
Query: 71 DELGQGGYGRVYKG--KLSDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+++G+G YG VYK KL+ G +VA+K L ++G I E++ + +H N+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 126 LGFCLEGSKRALIYEFM 142
L +K L++E +
Sbjct: 67 LDVIHTENKLYLVFEHV 83
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 36.6 bits (83), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 43/78 (55%), Gaps = 2/78 (2%)
Query: 71 DELGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFC 129
++LG+G YG VYK + G++VA+K + + + QE I E++ + + +VV G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPV-ESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 130 LEGSKRALIYEFMPNGSL 147
+ + ++ E+ GS+
Sbjct: 94 FKNTDLWIVMEYCGAGSV 111
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 36.6 bits (83), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I E+ G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREY 131
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 36.6 bits (83), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 68 SFKDELGQGGYGRVYKGKL---SDGRL-VAVKLLNTSKGNGQ--EFINEVASISRTSHVN 121
S +G G +G V G+L S + VA+K L Q +F+ E + + + H N
Sbjct: 19 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 78
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ L G + ++ E M NGSL+ F
Sbjct: 79 IIRLEGVVTKSKPVMIVTEXMENGSLDSF 107
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 36.6 bits (83), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 68 SFKDELGQGGYGRVYK-GKLSDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTL 125
+ELG G +G V++ + + G A K + T + +E + E+ ++S H +V L
Sbjct: 54 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 113
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
+ ++ +IYEFM G L
Sbjct: 114 HDAFEDDNEMVMIYEFMSGGEL 135
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 36.6 bits (83), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCL-E 131
+G+G +G V G G VAVK + Q F+ E + +++ H N+V LLG + E
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 132 GSKRALIYEFMPNGSLEKF 150
++ E+M GSL +
Sbjct: 87 KGGLYIVTEYMAKGSLVDY 105
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 36.6 bits (83), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 29/123 (23%), Positives = 56/123 (45%), Gaps = 14/123 (11%)
Query: 39 DQDLEAFIRNYVSLAPERYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGR 90
D + A + Y ++ FP K + LG+G +G+V K K +
Sbjct: 4 DTPMLAGVSEYELPEDPKWEFPRDKL---TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAV 60
Query: 91 LVAVKLL--NTSKGNGQEFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
VAVK+L + ++ + + ++E+ + H N++ LLG C + +I E+ G+L
Sbjct: 61 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 148 EKF 150
++
Sbjct: 121 REY 123
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 36.6 bits (83), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCL-E 131
+G+G +G V G G VAVK + + Q F+ E + +++ H N+V LLG + E
Sbjct: 20 IGKGEFGDVMLGDYR-GNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 132 GSKRALIYEFMPNGSLEKF 150
++ E+M GSL +
Sbjct: 78 KGGLYIVTEYMAKGSLVDY 96
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 36.2 bits (82), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 2/82 (2%)
Query: 68 SFKDELGQGGYGRVYK-GKLSDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTL 125
+ELG G +G V++ + + G A K + T + +E + E+ ++S H +V L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
+ ++ +IYEFM G L
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGEL 241
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 35.8 bits (81), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 16 KWEFPRDKL---TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 72
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I E+ G+L ++
Sbjct: 73 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 118
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 35.8 bits (81), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 18 KWEFPRDKL---TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 74
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I E+ G+L ++
Sbjct: 75 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 120
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 35.8 bits (81), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 21/61 (34%), Positives = 36/61 (59%), Gaps = 5/61 (8%)
Query: 73 LGQGGYGRVYKGKLS-DGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
+G GG+G+V+K K DG+ +K + K N ++ EV ++++ HVN+V G C +
Sbjct: 19 IGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNG-CWD 74
Query: 132 G 132
G
Sbjct: 75 G 75
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 35.8 bits (81), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 1/90 (1%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHV 120
V + T + LG G G V+ G + VAVK L + F+ E + + H
Sbjct: 9 EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 121 NVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+V L + +I E+M NGSL F
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 35.8 bits (81), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLEG 132
LG G +G V+ G + VA+K L + + F+ E + + H +V L E
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE- 75
Query: 133 SKRALIYEFMPNGSLEKF 150
++ E+M GSL F
Sbjct: 76 EPIYIVTEYMNKGSLLDF 93
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 35.4 bits (80), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQE--FINEVASISRTSHVNV 122
F+D LG G + V + D R LVA+K + G+E NE+A + + H N+
Sbjct: 21 DFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
V L G LI + + G L
Sbjct: 79 VALDDIYESGGHLYLIMQLVSGGEL 103
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 35.4 bits (80), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 12/90 (13%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTS--------H 119
+ ++ +G GG+G+VY+ G VAVK ++ + E I++ R H
Sbjct: 10 TLEEIIGIGGFGKVYRA-FWIGDEVAVK---AARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 120 VNVVTLLGFCLEGSKRALIYEFMPNGSLEK 149
N++ L G CL+ L+ EF G L +
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNR 95
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 35.4 bits (80), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQE--FINEVASISRTSHVNV 122
F+D LG G + V + D R LVA+K + G+E NE+A + + H N+
Sbjct: 21 DFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
V L G LI + + G L
Sbjct: 79 VALDDIYESGGHLYLIMQLVSGGEL 103
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 35.4 bits (80), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQE--FINEVASISRTSHVNV 122
F+D LG G + V + D R LVA+K + G+E NE+A + + H N+
Sbjct: 21 DFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
V L G LI + + G L
Sbjct: 79 VALDDIYESGGHLYLIMQLVSGGEL 103
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 35.4 bits (80), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 24/65 (36%), Positives = 32/65 (49%), Gaps = 7/65 (10%)
Query: 72 ELGQGGYGRVYKGK-LSDGRLVA---VKLLNTSKGNGQEFINEVASISRT---SHVNVVT 124
E+G G YG VYK + G VA V++ N +G + EVA + R H NVV
Sbjct: 11 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 125 LLGFC 129
L+ C
Sbjct: 71 LMDVC 75
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 35.4 bits (80), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 24/65 (36%), Positives = 32/65 (49%), Gaps = 7/65 (10%)
Query: 72 ELGQGGYGRVYKGK-LSDGRLVA---VKLLNTSKGNGQEFINEVASISRT---SHVNVVT 124
E+G G YG VYK + G VA V++ N +G + EVA + R H NVV
Sbjct: 11 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 125 LLGFC 129
L+ C
Sbjct: 71 LMDVC 75
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 35.0 bits (79), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 24/65 (36%), Positives = 32/65 (49%), Gaps = 7/65 (10%)
Query: 72 ELGQGGYGRVYKGK-LSDGRLVA---VKLLNTSKGNGQEFINEVASISRT---SHVNVVT 124
E+G G YG VYK + G VA V++ N +G + EVA + R H NVV
Sbjct: 11 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 125 LLGFC 129
L+ C
Sbjct: 71 LMDVC 75
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 35.0 bits (79), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTY 122
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 35.0 bits (79), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTY 122
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 35.0 bits (79), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTY 122
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 35.0 bits (79), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTY 122
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 35.0 bits (79), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTY 124
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 35.0 bits (79), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTY 123
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 35.0 bits (79), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTY 124
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 35.0 bits (79), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTY 113
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 35.0 bits (79), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 20/61 (32%), Positives = 36/61 (59%), Gaps = 5/61 (8%)
Query: 73 LGQGGYGRVYKGKLS-DGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
+G GG+G+V+K K DG+ ++ + K N ++ EV ++++ HVN+V G C +
Sbjct: 20 IGSGGFGQVFKAKHRIDGKTYVIRRV---KYNNEKAEREVKALAKLDHVNIVHYNG-CWD 75
Query: 132 G 132
G
Sbjct: 76 G 76
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 35.0 bits (79), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 36/77 (46%), Gaps = 2/77 (2%)
Query: 73 LGQGGYGRVYKGK-LSDGRLVAVKLLNTSKGN-GQEFINEVASISRTSHVNVVTLLGFCL 130
LG+G YG VY G+ LS+ +A+K + Q E+A H N+V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 131 EGSKRALIYEFMPNGSL 147
E + E +P GSL
Sbjct: 90 ENGFIKIFMEQVPGGSL 106
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 35.0 bits (79), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQE--FINEVASISRTSHVNV 122
F+D LG G + V + D R LVA+K + G+E NE+A + + H N+
Sbjct: 21 DFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
V L G LI + + G L
Sbjct: 79 VALDDIYESGGHLYLIMQLVSGGEL 103
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 35.0 bits (79), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTY 122
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 34.7 bits (78), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 39/84 (46%), Gaps = 4/84 (4%)
Query: 68 SFKDELGQGGYGRVYKGKLSDGRLVA--VKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
+F +L + G ++KG+ +V +K+ + S ++F E + SH NV+ +
Sbjct: 13 NFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 126 LGFC--LEGSKRALIYEFMPNGSL 147
LG C LI + P GSL
Sbjct: 73 LGACQSPPAPHPTLITHWXPYGSL 96
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 34.7 bits (78), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTY 159
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 34.7 bits (78), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 26/77 (33%), Positives = 36/77 (46%), Gaps = 2/77 (2%)
Query: 73 LGQGGYGRVYKGK-LSDGRLVAVKLLNTSKGN-GQEFINEVASISRTSHVNVVTLLGFCL 130
LG+G YG VY G+ LS+ +A+K + Q E+A H N+V LG
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 131 EGSKRALIYEFMPNGSL 147
E + E +P GSL
Sbjct: 76 ENGFIKIFMEQVPGGSL 92
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 34.7 bits (78), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTY 113
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 34.7 bits (78), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTY 113
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 34.7 bits (78), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTY 117
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 34.7 bits (78), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 73 LGQGGYGRVYKGKLSDGRLV-AVKLLNTSK----GNGQEFINEVASISRTSHVNVVTLLG 127
LG+G +G VY + + + A+K+L S+ G + E+ S H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 128 FCLEGSKRALIYEFMPNGSLEK 149
+ + + L+ EF P G L K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYK 103
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 34.7 bits (78), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 28 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 88 NLLGACTKPGGPLMVIVEFCKFGNLSTY 115
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 34.7 bits (78), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTY 122
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 34.7 bits (78), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTY 124
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 34.7 bits (78), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--FINEVASISRT-SHVNVV 123
LG+G +G+V + K + R VAVK+L + + ++E+ + H+NVV
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 TLLGFCLE-GSKRALIYEFMPNGSLEKF 150
LLG C + G +I EF G+L +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTY 113
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 34.7 bits (78), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 73 LGQGGYGRVYKGKLSDGRLV-AVKLLNTSK----GNGQEFINEVASISRTSHVNVVTLLG 127
LG+G +G VY + + + A+K+L S+ G + E+ S H N++ +
Sbjct: 23 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 128 FCLEGSKRALIYEFMPNGSLEK 149
+ + + L+ EF P G L K
Sbjct: 83 YFHDRKRIYLMLEFAPRGELYK 104
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 34.7 bits (78), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 73 LGQGGYGRVYKGKLSDGRLV-AVKLLNTSK----GNGQEFINEVASISRTSHVNVVTLLG 127
LG+G +G VY + + + A+K+L S+ G + E+ S H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 128 FCLEGSKRALIYEFMPNGSLEK 149
+ + + L+ EF P G L K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYK 103
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 34.7 bits (78), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 23/82 (28%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 73 LGQGGYGRVYKGKLSDGR-LVAVKLLNTSK----GNGQEFINEVASISRTSHVNVVTLLG 127
LG+G +G VY + +VA+K+L S+ G + E+ + H N++ L
Sbjct: 31 LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 128 FCLEGSKRALIYEFMPNGSLEK 149
+ + + LI E+ P G L K
Sbjct: 91 YFYDRRRIYLILEYAPRGELYK 112
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 34.7 bits (78), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 25/106 (23%), Positives = 50/106 (47%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I + G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREY 131
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 34.7 bits (78), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 61 NVKKMTNSFKDELGQGGYGRVY--KGKLSDGRLVAVKLLNTSKG-NGQEFINEVASISRT 117
N++K T F + LG G + V+ K +L+ G+L A+K + S NE+A + +
Sbjct: 6 NIRK-TFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 118 SHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
H N+VTL + L+ + + G L
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGEL 93
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 34.3 bits (77), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREY 109
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 34.3 bits (77), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 19/75 (25%), Positives = 35/75 (46%), Gaps = 4/75 (5%)
Query: 71 DELGQGGYGRVYKGKLSDGRLVA----VKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+++G+G YG V+K K + + V+L + +G + E+ + H N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 127 GFCLEGSKRALIYEF 141
K L++EF
Sbjct: 68 DVLHSDKKLTLVFEF 82
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 34.3 bits (77), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 72 ELGQGGYGRVYKGK--LSDGRLVAVKLLNTSKG-NGQEF--INEVASISRT---SHVNVV 123
E+G+G YG+V+K + + GR VA+K + G G I EVA + H NVV
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 124 TLLGFC 129
L C
Sbjct: 78 RLFDVC 83
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 34.3 bits (77), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 19/75 (25%), Positives = 35/75 (46%), Gaps = 4/75 (5%)
Query: 71 DELGQGGYGRVYKGKLSDGRLVA----VKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
+++G+G YG V+K K + + V+L + +G + E+ + H N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 127 GFCLEGSKRALIYEF 141
K L++EF
Sbjct: 68 DVLHSDKKLTLVFEF 82
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 34.3 bits (77), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREY 124
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 34.3 bits (77), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREY 117
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 34.3 bits (77), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 72 ELGQGGYGRVYKGK--LSDGRLVAVKLLNTSKG-NGQEF--INEVASISRT---SHVNVV 123
E+G+G YG+V+K + + GR VA+K + G G I EVA + H NVV
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 124 TLLGFC 129
L C
Sbjct: 78 RLFDVC 83
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 34.3 bits (77), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREY 113
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 34.3 bits (77), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREY 124
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 34.3 bits (77), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREY 124
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 34.3 bits (77), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREY 124
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 34.3 bits (77), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 24/66 (36%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 72 ELGQGGYGRVYKGK--LSDGRLVAVKLLNTSKG-NGQEF--INEVASISRT---SHVNVV 123
E+G+G YG+V+K + + GR VA+K + G G I EVA + H NVV
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 124 TLLGFC 129
L C
Sbjct: 78 RLFDVC 83
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 33.9 bits (76), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREY 116
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 33.9 bits (76), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 20/75 (26%), Positives = 36/75 (48%), Gaps = 3/75 (4%)
Query: 71 DELGQGGYGRVYKGKLSDGRLVAVKLLNTSK---GNGQEFINEVASISRTSHVNVVTLLG 127
+++G+G YG VYK + + G A+K + K G I E++ + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 128 FCLEGSKRALIYEFM 142
+ L++E +
Sbjct: 68 VIHTKKRLVLVFEHL 82
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 33.9 bits (76), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 20/75 (26%), Positives = 36/75 (48%), Gaps = 3/75 (4%)
Query: 71 DELGQGGYGRVYKGKLSDGRLVAVKLLNTSK---GNGQEFINEVASISRTSHVNVVTLLG 127
+++G+G YG VYK + + G A+K + K G I E++ + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 128 FCLEGSKRALIYEFM 142
+ L++E +
Sbjct: 68 VIHTKKRLVLVFEHL 82
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 33.9 bits (76), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 10/88 (11%)
Query: 73 LGQGGYGRVYKG------KLSDGRLVAVKLLN--TSKGNGQEFINEVASISRT-SHVNVV 123
LG+G +G+V + K R VAVK+L + + + E+ ++ H+NVV
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 124 TLLGFCL-EGSKRALIYEFMPNGSLEKF 150
LLG C +G +I E+ G+L +
Sbjct: 95 NLLGACTKQGGPLMVIVEYCKYGNLSNY 122
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 33.9 bits (76), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 20/75 (26%), Positives = 36/75 (48%), Gaps = 3/75 (4%)
Query: 71 DELGQGGYGRVYKGKLSDGRLVAVKLLNTSK---GNGQEFINEVASISRTSHVNVVTLLG 127
+++G+G YG VYK + + G A+K + K G I E++ + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 128 FCLEGSKRALIYEFM 142
+ L++E +
Sbjct: 68 VIHTKKRLVLVFEHL 82
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 33.9 bits (76), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 73 LGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQEFINEVASISRT-SHVN 121
LG+G +G+V K K + VAVK+L + ++ + + I+E+ + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 122 VVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
++ LLG C + +I E+ G+L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREY 165
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 33.9 bits (76), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 25/106 (23%), Positives = 50/106 (47%), Gaps = 14/106 (13%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVY--------KGKLSDGRLVAVKLL--NTSKGNGQ 105
++ FP K + LG+G +G+V K K + VAVK+L + ++ +
Sbjct: 29 KWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 106 EFINEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ ++E+ + H N++ LLG C + +I + G+L ++
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREY 131
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 33.5 bits (75), Expect = 0.042, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 37/70 (52%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 131 -EGSKRALIY 139
G K+ ++Y
Sbjct: 84 SSGEKKDVVY 93
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 33.5 bits (75), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 21/79 (26%), Positives = 41/79 (51%), Gaps = 2/79 (2%)
Query: 71 DELGQGGYGRVYKG-KLSDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGF 128
+ELG G +G V++ + + GR+ K +NT + + NE++ +++ H ++ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 129 CLEGSKRALIYEFMPNGSL 147
+ + LI EF+ G L
Sbjct: 117 FEDKYEMVLILEFLSGGEL 135
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 33.5 bits (75), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 2/78 (2%)
Query: 72 ELGQGGYGRV-YKGKLSDGRLVAVKLLNTSKGNGQEFI-NEVASISRTSHVNVVTLLGFC 129
++G+G G V + G+ VAVK ++ K +E + NEV + H NVV +
Sbjct: 52 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 130 LEGSKRALIYEFMPNGSL 147
L G + ++ EF+ G+L
Sbjct: 112 LVGDELWVVMEFLEGGAL 129
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 33.1 bits (74), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 4/90 (4%)
Query: 61 NVKKMTNSFKDELGQGGYGRVYKGKL-SDGRLVAVKLL--NTSKGNGQEFINEVASISRT 117
++KK+ FK+ LG G + V + + G+L AVK + KG NE+A + +
Sbjct: 19 DIKKIFE-FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 118 SHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
H N+V L + L+ + + G L
Sbjct: 78 KHENIVALEDIYESPNHLYLVMQLVSGGEL 107
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 33.1 bits (74), Expect = 0.056, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 37/70 (52%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + G+ F N E+ + + H N+V L F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 84 SSGEKKDEVY 93
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 33.1 bits (74), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 37/70 (52%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + G+ F N E+ + + H N+V L F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 84 SSGEKKDEVY 93
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 33.1 bits (74), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 37/70 (52%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + G+ F N E+ + + H N+V L F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 84 SSGEKKDEVY 93
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 33.1 bits (74), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 7/79 (8%)
Query: 71 DELGQGGYGRVYKGKLSD-GRLVAVKLL------NTSKGNGQEFINEVASISRTSHVNVV 123
D LG+G + VYK + + ++VA+K + G + + E+ + SH N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 124 TLLGFCLEGSKRALIYEFM 142
LL S +L+++FM
Sbjct: 76 GLLDAFGHKSNISLVFDFM 94
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 33.1 bits (74), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 21/83 (25%), Positives = 43/83 (51%), Gaps = 4/83 (4%)
Query: 72 ELGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNG---QEFINEVASISRTSHVNVVTLLG 127
++G+G YG V+K + D G++VA+K S+ + + + E+ + + H N+V LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
+ L++E+ + L +
Sbjct: 70 VFRRKRRLHLVFEYCDHTVLHEL 92
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 33.1 bits (74), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 25/81 (30%), Positives = 38/81 (46%), Gaps = 7/81 (8%)
Query: 73 LGQGGYGRVY--KGKLSDGRLVAVKLLN----TSKGNGQEFINEVASISRTSHVNVVTLL 126
LG G YG V K KL+ G A+K++ T+ N ++EVA + + H N++ L
Sbjct: 12 LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
F + L+ E G L
Sbjct: 71 EFFEDKRNYYLVMEVYRGGEL 91
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 32.7 bits (73), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 23/83 (27%), Positives = 41/83 (49%), Gaps = 5/83 (6%)
Query: 72 ELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
++G+G YG V+ GK G VAVK+ T++ E+ H N++ + ++
Sbjct: 44 QIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 132 G----SKRALIYEFMPNGSLEKF 150
G ++ LI ++ NGSL +
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDY 125
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 32.7 bits (73), Expect = 0.076, Method: Compositional matrix adjust.
Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 7/82 (8%)
Query: 72 ELGQGGYGRVY--KGKLSDGRLVAVKLLN----TSKGNGQEFINEVASISRTSHVNVVTL 125
+LG G YG V K KL+ G A+K++ T+ N ++EVA + + H N++ L
Sbjct: 28 KLGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 126 LGFCLEGSKRALIYEFMPNGSL 147
F + L+ E G L
Sbjct: 87 YEFFEDKRNYYLVMEVYRGGEL 108
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 32.7 bits (73), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 71 DELGQGGYGRVYKGKLS--DGRLV--AVKLLNTSKGNGQE----FINEVASISRTSHVNV 122
++LG G +G V +G+ G+ V AVK L + E FI EV ++ H N+
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
+ L G L + ++ E P GSL
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSL 101
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 32.7 bits (73), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 71 DELGQGGYGRVYKGKLS--DGRLV--AVKLLNTSKGNGQE----FINEVASISRTSHVNV 122
++LG G +G V +G+ G+ V AVK L + E FI EV ++ H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
+ L G L + ++ E P GSL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 32.7 bits (73), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 71 DELGQGGYGRVYKGKLS--DGRLV--AVKLLNTSKGNGQE----FINEVASISRTSHVNV 122
++LG G +G V +G+ G+ V AVK L + E FI EV ++ H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
+ L G L + ++ E P GSL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 32.7 bits (73), Expect = 0.082, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 71 DELGQGGYGRVYKGKLS--DGRLV--AVKLLNTSKGNGQE----FINEVASISRTSHVNV 122
++LG G +G V +G+ G+ V AVK L + E FI EV ++ H N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
+ L G L + ++ E P GSL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 32.7 bits (73), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 71 DELGQGGYGRVYKGKLS--DGRLV--AVKLLNTSKGNGQE----FINEVASISRTSHVNV 122
++LG G +G V +G+ G+ V AVK L + E FI EV ++ H N+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
+ L G L + ++ E P GSL
Sbjct: 84 IRLYGVVLTPPMK-MVTELAPLGSL 107
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 32.7 bits (73), Expect = 0.089, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 71 DELGQGGYGRVYKGKLS--DGRLV--AVKLLNTSKGNGQE----FINEVASISRTSHVNV 122
++LG G +G V +G+ G+ V AVK L + E FI EV ++ H N+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
+ L G L + ++ E P GSL
Sbjct: 84 IRLYGVVLTPPMK-MVTELAPLGSL 107
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 32.3 bits (72), Expect = 0.091, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 9/85 (10%)
Query: 71 DELGQGGYGRVYKGKLS--DGRLV--AVKLLNTSKGNGQE----FINEVASISRTSHVNV 122
++LG G +G V +G+ G+ V AVK L + E FI EV ++ H N+
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSL 147
+ L G L + ++ E P GSL
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSL 101
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 32.3 bits (72), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 1/82 (1%)
Query: 69 FKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGF 128
+ +LG G +G V+ + VAVK + + + F+ E + H +V L
Sbjct: 19 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 77
Query: 129 CLEGSKRALIYEFMPNGSLEKF 150
+ +I EFM GSL F
Sbjct: 78 VVTKEPIYIITEFMAKGSLLDF 99
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 32.3 bits (72), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 20/77 (25%), Positives = 41/77 (53%), Gaps = 2/77 (2%)
Query: 73 LGQGGYGRVYK-GKLSDGRLVAVKLLNT-SKGNGQEFINEVASISRTSHVNVVTLLGFCL 130
LG G +G+V+K + + G +A K++ T + +E NE++ +++ H N++ L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 131 EGSKRALIYEFMPNGSL 147
+ L+ E++ G L
Sbjct: 157 SKNDIVLVMEYVDGGEL 173
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 32.0 bits (71), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 41 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 97 SSGEKKDEVY 106
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 32.0 bits (71), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 64 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 120 SSGEKKDEVY 129
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 84 SSGEKKDEVY 93
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 84 SSGEKKDEVY 93
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 84 SSGEKKDEVY 93
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 56 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 112 SSGEKKDEVY 121
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 118 SSGEKKDEVY 127
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 118 SSGEKKDEVY 127
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 29 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 85 SSGEKKDEVY 94
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 47 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 103 SSGEKKDEVY 112
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 36 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 92 SSGEKKDEVY 101
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 56 RYSFPNVKKMTNSFKDELGQGGYGRVYKG------KLSDGRLVAVKLLNTSKGNGQE--F 107
++ FP + F LG G +G+V K VAVK+L + +
Sbjct: 39 KWEFP---RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL 95
Query: 108 INEVASISRT-SHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
++E+ +++ SH N+V LLG C LI+E+ G L
Sbjct: 96 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 136
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 32 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 88 SSGEKKDEVY 97
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 32.0 bits (71), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 40 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 96 SSGEKKDEVY 105
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 32.0 bits (71), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 40 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 96 SSGEKKDEVY 105
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 32.0 bits (71), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 66 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 122 SSGEKKDEVY 131
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 32.0 bits (71), Expect = 0.14, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 1/82 (1%)
Query: 69 FKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGF 128
+ +LG G +G V+ + VAVK + + + F+ E + H +V L
Sbjct: 186 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA- 244
Query: 129 CLEGSKRALIYEFMPNGSLEKF 150
+ +I EFM GSL F
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDF 266
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 32.0 bits (71), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 163 SSGEKKDEVY 172
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 32.0 bits (71), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 7/70 (10%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCL 130
+G G +G VY+ KL D G LVA+K + K F N E+ + + H N+V L F
Sbjct: 33 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 131 -EGSKRALIY 139
G K+ +Y
Sbjct: 89 SSGEKKDEVY 98
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 31.6 bits (70), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 1/82 (1%)
Query: 69 FKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGF 128
+ +LG G +G V+ + VAVK + + + F+ E + H +V L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 129 CLEGSKRALIYEFMPNGSLEKF 150
+ +I EFM GSL F
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDF 272
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 31.6 bits (70), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 22/81 (27%), Positives = 36/81 (44%), Gaps = 3/81 (3%)
Query: 69 FKDELGQGGYG--RVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLL 126
F ++G G +G R+ + KL+ LVAVK + + E+ + H N+V
Sbjct: 24 FVKDIGSGNFGVARLMRDKLT-KELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
L + A+I E+ G L
Sbjct: 83 EVILTPTHLAIIMEYASGGEL 103
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 31.2 bits (69), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 20/79 (25%), Positives = 41/79 (51%), Gaps = 3/79 (3%)
Query: 71 DELGQGGYGRVYKGKLSDGR-LVAVKLLNTSKGNGQEFI--NEVASISRTSHVNVVTLLG 127
D +G+G +G VYKG + + +VA+K+++ + + E+ +S+ + G
Sbjct: 25 DRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 128 FCLEGSKRALIYEFMPNGS 146
L+ +K +I E++ GS
Sbjct: 85 SYLKSTKLWIIMEYLGGGS 103
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 31.2 bits (69), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 71 DELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQEFI--NEVASISRTSHVNVVTL 125
+ +G+G +G V+KG D R +VA+K+++ + + E+ +S+ V
Sbjct: 29 ERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKY 86
Query: 126 LGFCLEGSKRALIYEFMPNGS 146
G L+GSK +I E++ GS
Sbjct: 87 YGSYLKGSKLWIIMEYLGGGS 107
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 30.8 bits (68), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
++GQG +G V+K + G+ VA+K + N +G + E+ + H NVV L+
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 128 FC 129
C
Sbjct: 84 IC 85
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 30.8 bits (68), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
++GQG +G V+K + G+ VA+K + N +G + E+ + H NVV L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 128 FC 129
C
Sbjct: 85 IC 86
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 30.8 bits (68), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
++GQG +G V+K + G+ VA+K + N +G + E+ + H NVV L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 128 FC 129
C
Sbjct: 85 IC 86
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 30.8 bits (68), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 19/62 (30%), Positives = 32/62 (51%), Gaps = 4/62 (6%)
Query: 72 ELGQGGYGRVYKGKL-SDGRLVAVK---LLNTSKGNGQEFINEVASISRTSHVNVVTLLG 127
++GQG +G V+K + G+ VA+K + N +G + E+ + H NVV L+
Sbjct: 25 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 128 FC 129
C
Sbjct: 85 IC 86
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 30.4 bits (67), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 73 LGQGGYGRVYKGKLS-DGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
LGQG +G+V K + + D R A+K + ++ ++EV ++ +H VV LE
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 30.4 bits (67), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 15 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL 92
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.4 bits (67), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 30.4 bits (67), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 13 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 70 GHRREGNIQYLFLEYCSGGEL 90
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.4 bits (67), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 30.4 bits (67), Expect = 0.39, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 30.4 bits (67), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 73 LGQGGYGRVYKGKLS-DGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
LGQG +G+V K + + D R A+K + ++ ++EV ++ +H VV LE
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 30.4 bits (67), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 15 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 71
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL 92
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 30.4 bits (67), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 20/83 (24%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 73 LGQGGYGRVYKGK-LSDGRLVAVKLLNTSK----GNGQEFINEVASISRTSHVNVVTLLG 127
LG+G + VY+ + + G VA+K+++ G Q NEV + H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 128 FCLEGSKRALIYEFMPNGSLEKF 150
+ + + L+ E NG + ++
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRY 101
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 30.4 bits (67), Expect = 0.40, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 30.4 bits (67), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 18/60 (30%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 73 LGQGGYGRVYKGKLS-DGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCLE 131
LGQG +G+V K + + D R A+K + ++ ++EV ++ +H VV LE
Sbjct: 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.4 bits (67), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 30.4 bits (67), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 30.4 bits (67), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 15 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL 92
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.4 bits (67), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 30.4 bits (67), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 30.4 bits (67), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 30.4 bits (67), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 24/68 (35%), Positives = 31/68 (45%), Gaps = 10/68 (14%)
Query: 72 ELGQGGYGRVYKGK-LSDGRLVAVKLLNTSKGNGQEF------INEVASISRT---SHVN 121
E+G G YG VYK + G VA+K + G G + EVA + R H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 122 VVTLLGFC 129
VV L+ C
Sbjct: 76 VVRLMDVC 83
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 30.0 bits (66), Expect = 0.46, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 30.0 bits (66), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 15 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL 92
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 30.0 bits (66), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 15 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL 92
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 30.0 bits (66), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 15 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL 92
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 30.0 bits (66), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 39/81 (48%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKGNG--QEFINEVASISRTSHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E+ + +H NVV
Sbjct: 15 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFY 71
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL 92
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 30.0 bits (66), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 15 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 72 GHRREGNIQYLFLEYCSGGEL 92
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 30.0 bits (66), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G YG V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 29.6 bits (65), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 42/84 (50%), Gaps = 9/84 (10%)
Query: 73 LGQGGYGRVYKGK----LSDGRLVAVKLLNTSK--GNGQEFINEVAS---ISRTSHVNVV 123
LG+GGYG+V++ + + G++ A+K+L + N ++ + A + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 124 TLLGFCLEGSKRALIYEFMPNGSL 147
L+ G K LI E++ G L
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGEL 108
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 29.6 bits (65), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 23/85 (27%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 71 DELGQGGYGRVYKGKLSDGRL-VAVKLLNTSKGNGQE----FINEVASISRTSHVNVVTL 125
D+LG GG VY + + + VA+K + +E F EV + S+ SH N+V++
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 126 LGFCLEGSKRALIYEFMPNGSLEKF 150
+ E L+ E++ +L ++
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEY 101
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 29.6 bits (65), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 23/84 (27%), Positives = 42/84 (50%), Gaps = 9/84 (10%)
Query: 73 LGQGGYGRVYKGK----LSDGRLVAVKLLNTSK--GNGQEFINEVAS---ISRTSHVNVV 123
LG+GGYG+V++ + + G++ A+K+L + N ++ + A + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 124 TLLGFCLEGSKRALIYEFMPNGSL 147
L+ G K LI E++ G L
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGEL 108
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 29.3 bits (64), Expect = 0.89, Method: Compositional matrix adjust.
Identities = 18/77 (23%), Positives = 37/77 (48%), Gaps = 2/77 (2%)
Query: 73 LGQGGYGRVYK--GKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFCL 130
LG+G +G+ K + + +V +L+ + + F+ EV + H NV+ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 131 EGSKRALIYEFMPNGSL 147
+ + I E++ G+L
Sbjct: 78 KDKRLNFITEYIKGGTL 94
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 28.9 bits (63), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 27/104 (25%), Positives = 47/104 (45%), Gaps = 6/104 (5%)
Query: 50 VSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYKGKLS-DGRLVAVKLLNTSKGNG---Q 105
V L E F +++K K +G+G +G+ K + DGR +K +N S+ + +
Sbjct: 11 VDLGTENLYFQSMEKYVRLQK--IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 106 EFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEK 149
E EVA ++ H N+V E ++ ++ G L K
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFK 112
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 28.9 bits (63), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 25/78 (32%), Positives = 36/78 (46%), Gaps = 11/78 (14%)
Query: 73 LGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISR-TSHVNVVTLLGFCLE 131
+G G +G V++ KL + VA+K + K F N I R H NVV L F
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 132 -GSKRA-----LIYEFMP 143
G K+ L+ E++P
Sbjct: 104 NGDKKDEVFLNLVLEYVP 121
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 28.1 bits (61), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 72 ELGQGGYG--RVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFC 129
++G G +G R+ + K S+ LVAVK + + + E+ + H N+V
Sbjct: 26 DIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 130 LEGSKRALIYEFMPNGSL 147
L + A++ E+ G L
Sbjct: 85 LTPTHLAIVMEYASGGEL 102
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 28.1 bits (61), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 71 DELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQEFI--NEVASISRTSHVNVVTL 125
+++G+G +G V+KG D R +VA+K+++ + + E+ +S+ V
Sbjct: 13 EKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 126 LGFCLEGSKRALIYEFMPNGS 146
G L+ +K +I E++ GS
Sbjct: 71 YGSYLKDTKLWIIMEYLGGGS 91
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 28.1 bits (61), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 71 DELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQEFI--NEVASISRTSHVNVVTL 125
+++G+G +G V+KG D R +VA+K+++ + + E+ +S+ V
Sbjct: 13 EKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 126 LGFCLEGSKRALIYEFMPNGS 146
G L+ +K +I E++ GS
Sbjct: 71 YGSYLKDTKLWIIMEYLGGGS 91
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 28.1 bits (61), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 72 ELGQGGYG--RVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFC 129
++G G +G R+ + K S+ LVAVK + + + E+ + H N+V
Sbjct: 25 DIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 130 LEGSKRALIYEFMPNGSL 147
L + A++ E+ G L
Sbjct: 84 LTPTHLAIVMEYASGGEL 101
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 28.1 bits (61), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 72 ELGQGGYG--RVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFC 129
++G G +G R+ + K S+ LVAVK + + + E+ + H N+V
Sbjct: 26 DIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 130 LEGSKRALIYEFMPNGSL 147
L + A++ E+ G L
Sbjct: 85 LTPTHLAIVMEYASGGEL 102
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 28.1 bits (61), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 25/80 (31%), Positives = 35/80 (43%), Gaps = 10/80 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 16 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 123 VTLLGFCLEGSKRALIYEFM 142
+ LL + LI E M
Sbjct: 76 IRLLDWFERPDSFVLILERM 95
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 28.1 bits (61), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 71 DELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQEFI--NEVASISRTSHVNVVTL 125
+++G+G +G V+KG D R +VA+K+++ + + E+ +S+ V
Sbjct: 28 EKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 126 LGFCLEGSKRALIYEFMPNGS 146
G L+ +K +I E++ GS
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGS 106
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 28.1 bits (61), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 7/81 (8%)
Query: 71 DELGQGGYGRVYKGKLSDGR---LVAVKLLNTSKGNGQEFI--NEVASISRTSHVNVVTL 125
+++G+G +G V+KG D R +VA+K+++ + + E+ +S+ V
Sbjct: 33 EKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 126 LGFCLEGSKRALIYEFMPNGS 146
G L+ +K +I E++ GS
Sbjct: 91 YGSYLKDTKLWIIMEYLGGGS 111
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 28.1 bits (61), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 8/109 (7%)
Query: 50 VSLAPERYSFPNVKKMTNSFKDELGQGGYGRVYK------GKLSDGRLVAVKLLNTSKG- 102
V L E F ++ + +ELG G + V K GK + + + L +S+
Sbjct: 11 VDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRG 70
Query: 103 -NGQEFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+ +E EV + H N++TL + LI E + G L F
Sbjct: 71 VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDF 119
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 27.7 bits (60), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 66 TNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
T ++ +G+G +G V++GK G VAVK+ ++ + + + E A I +T + +
Sbjct: 5 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFRE-AEIYQTVMLRHENI 60
Query: 126 LGFCLEGSKR-------ALIYEFMPNGSL 147
LGF +K L+ ++ +GSL
Sbjct: 61 LGFIAADNKDNGTWTQLWLVSDYHEHGSL 89
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 27.7 bits (60), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 66 TNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
T ++ +G+G +G V++GK G VAVK+ ++ + + + E A I +T + +
Sbjct: 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFRE-AEIYQTVMLRHENI 59
Query: 126 LGFCLEGSKR-------ALIYEFMPNGSL 147
LGF +K L+ ++ +GSL
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSL 88
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 27.7 bits (60), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 66 TNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
T ++ +G+G +G V++GK G VAVK+ ++ + + + E A I +T + +
Sbjct: 10 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFRE-AEIYQTVMLRHENI 65
Query: 126 LGFCLEGSKR-------ALIYEFMPNGSL 147
LGF +K L+ ++ +GSL
Sbjct: 66 LGFIAADNKDNGTWTQLWLVSDYHEHGSL 94
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 27.7 bits (60), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 66 TNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
T ++ +G+G +G V++GK G VAVK+ ++ + + + E A I +T + +
Sbjct: 7 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFRE-AEIYQTVMLRHENI 62
Query: 126 LGFCLEGSKR-------ALIYEFMPNGSL 147
LGF +K L+ ++ +GSL
Sbjct: 63 LGFIAADNKDNGTWTQLWLVSDYHEHGSL 91
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 27.7 bits (60), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 35/78 (44%), Gaps = 3/78 (3%)
Query: 72 ELGQGGYG--RVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFC 129
++G G +G R+ + K S+ LVAVK + + E+ + H N+V
Sbjct: 26 DIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVI 84
Query: 130 LEGSKRALIYEFMPNGSL 147
L + A++ E+ G L
Sbjct: 85 LTPTHLAIVMEYASGGEL 102
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 27.3 bits (59), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 22/90 (24%), Positives = 36/90 (40%), Gaps = 15/90 (16%)
Query: 73 LGQGGYGRVYKGKLSDGRLV-AVKLLNTSKGN--------------GQEFINEVASISRT 117
LG G YG V K +G A+K++ S+ + +E NE++ +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 118 SHVNVVTLLGFCLEGSKRALIYEFMPNGSL 147
H N++ L + L+ EF G L
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL 133
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 27.3 bits (59), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 15/50 (30%), Positives = 24/50 (48%)
Query: 101 KGNGQEFINEVASISRTSHVNVVTLLGFCLEGSKRALIYEFMPNGSLEKF 150
K +F NE+ I+ + +T G + +IYE+M N S+ KF
Sbjct: 84 KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF 133
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 27.3 bits (59), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 66 TNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
T ++ +G+G +G V++GK G VAVK+ ++ + + + E A I +T + +
Sbjct: 43 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFRE-AEIYQTVMLRHENI 98
Query: 126 LGFCLEGSKR-------ALIYEFMPNGSL 147
LGF +K L+ ++ +GSL
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSL 127
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 27.3 bits (59), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 24/89 (26%), Positives = 45/89 (50%), Gaps = 11/89 (12%)
Query: 66 TNSFKDELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTL 125
T ++ +G+G +G V++GK G VAVK+ ++ + + + E A I +T + +
Sbjct: 30 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFRE-AEIYQTVMLRHENI 85
Query: 126 LGFCLEGSKR-------ALIYEFMPNGSL 147
LGF +K L+ ++ +GSL
Sbjct: 86 LGFIAADNKDNGTWTQLWLVSDYHEHGSL 114
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 27.3 bits (59), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 31 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 91 IRLLDWFERPDSFVLILE 108
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 27.3 bits (59), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 104 IRLLDWFERPDSFVLILE 121
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 27.3 bits (59), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 16 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 76 IRLLDWFERPDSFVLILE 93
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 27.3 bits (59), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 19/78 (24%), Positives = 36/78 (46%), Gaps = 3/78 (3%)
Query: 72 ELGQGGYG--RVYKGKLSDGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGFC 129
++G G +G R+ + K ++ LVAVK + + + E+ + H N+V
Sbjct: 26 DIGAGNFGVARLMRDKQAN-ELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 130 LEGSKRALIYEFMPNGSL 147
L + A++ E+ G L
Sbjct: 85 LTPTHLAIVMEYASGGEL 102
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 27.3 bits (59), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 77 IRLLDWFERPDSFVLILE 94
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 27.3 bits (59), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 77 IRLLDWFERPDSFVLILE 94
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 26.9 bits (58), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 17 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 77 IRLLDWFERPDSFVLILE 94
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 26.9 bits (58), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 32 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 92 IRLLDWFERPDSFVLILE 109
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 26.9 bits (58), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 59 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 119 IRLLDWFERPDSFVLILE 136
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 26.9 bits (58), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 31 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 91 IRLLDWFERPDSFVLILE 108
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 26.9 bits (58), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 105 IRLLDWFERPDSFVLILE 122
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 26.9 bits (58), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 104 IRLLDWFERPDSFVLILE 121
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 26.9 bits (58), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 104 IRLLDWFERPDSFVLILE 121
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 26.9 bits (58), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 32 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 92 IRLLDWFERPDSFVLILE 109
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 26.9 bits (58), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 44 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 104 IRLLDWFERPDSFVLILE 121
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 26.9 bits (58), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 105 IRLLDWFERPDSFVLILE 122
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 26.9 bits (58), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 32 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 92 IRLLDWFERPDSFVLILE 109
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 26.9 bits (58), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 33/77 (42%), Gaps = 5/77 (6%)
Query: 75 QGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCLEGS 133
Q G G+ Y K R +L ++ +G +E I EV + H N++TL +
Sbjct: 26 QKGTGKEYAAKFIKKR----RLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81
Query: 134 KRALIYEFMPNGSLEKF 150
LI E + G L F
Sbjct: 82 DVVLILELVSGGELFDF 98
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 26.9 bits (58), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 105 IRLLDWFERPDSFVLILE 122
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 26.9 bits (58), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 45 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 105 IRLLDWFERPDSFVLILE 122
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 26.9 bits (58), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 33/77 (42%), Gaps = 5/77 (6%)
Query: 75 QGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEFIN-EVASISRTSHVNVVTLLGFCLEGS 133
Q G G+ Y K R +L ++ +G +E I EV + H N++TL +
Sbjct: 33 QKGTGKEYAAKFIKKR----RLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 88
Query: 134 KRALIYEFMPNGSLEKF 150
LI E + G L F
Sbjct: 89 DVVLILELVSGGELFDF 105
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 26.9 bits (58), Expect = 4.2, Method: Compositional matrix adjust.
Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 9/81 (11%)
Query: 73 LGQGGYGRVYKGKLSDGRL----VAVKLLNTSKG-NGQEFINEVASISRT-SHVNVVTLL 126
LG+G G V +L+ R+ VAVK+++ + + E I + I++ +H NVV
Sbjct: 14 LGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 70
Query: 127 GFCLEGSKRALIYEFMPNGSL 147
G EG+ + L E+ G L
Sbjct: 71 GHRREGNIQYLFLEYCSGGEL 91
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 26.9 bits (58), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 111 IRLLDWFERPDSFVLILE 128
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 26.9 bits (58), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 64 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 124 IRLLDWFERPDSFVLILE 141
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 26.9 bits (58), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 72 IRLLDWFERPDSFVLILE 89
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 26.9 bits (58), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 59 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 119 IRLLDWFERPDSFVLILE 136
>pdb|1EQ1|A Chain A, Nmr Structure Of An Exchangeable Apolipoprotein-Manduca
Sexta Apolipophorin-Iii
Length = 166
Score = 26.9 bits (58), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 15/38 (39%), Positives = 23/38 (60%), Gaps = 1/38 (2%)
Query: 37 KSDQDLEAFIRNYVSLAPE-RYSFPNVKKMTNSFKDEL 73
K+ + LE +N A E R + P+V+K N+FKD+L
Sbjct: 71 KAKEALEQARQNVEKTAEELRKAHPDVEKEANAFKDKL 108
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 26.9 bits (58), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 15 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 75 IRLLDWFERPDSFVLILE 92
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 26.9 bits (58), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 72 IRLLDWFERPDSFVLILE 89
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 26.9 bits (58), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 39 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 99 IRLLDWFERPDSFVLILE 116
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 26.9 bits (58), Expect = 4.8, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSK-------GNGQEFINEVASISRTSH--VNV 122
LG GG+G VY G ++SD VA+K + + NG EV + + S V
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VTLLGFCLEGSKRALIYE 140
+ LL + LI E
Sbjct: 72 IRLLDWFERPDSFVLILE 89
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 26.6 bits (57), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 36/68 (52%), Gaps = 12/68 (17%)
Query: 73 LGQGGYGRVYKG-KLSDGRLVAVKLLNTSKGNGQEFIN-------EVASISRT----SHV 120
LG+GG+G V+ G +L+D VA+K++ ++ G ++ EVA + + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 121 NVVTLLGF 128
V+ LL +
Sbjct: 99 GVIRLLDW 106
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 26.2 bits (56), Expect = 7.6, Method: Compositional matrix adjust.
Identities = 21/68 (30%), Positives = 32/68 (47%), Gaps = 2/68 (2%)
Query: 72 ELGQGGYGRVYKGKLSDGRLVAVKLLNTSKGNGQEF--INEVASISRTSHVNVVTLLGFC 129
++G+G YG VYK K DG+ L +G G E+A + H NV++L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 130 LEGSKRAL 137
L + R +
Sbjct: 88 LSHADRKV 95
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 26.2 bits (56), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 71 DELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNG-------QEFINEVASISRTSHVNV 122
+ELG G + V K + S G A K + + +E EV+ + + H NV
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+TL + LI E + G L F
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDF 105
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 26.2 bits (56), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 71 DELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNG-------QEFINEVASISRTSHVNV 122
+ELG G + V K + S G A K + + +E EV+ + + H NV
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+TL + LI E + G L F
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDF 105
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1
(Pkmyt1)
Length = 311
Score = 26.2 bits (56), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 14/24 (58%), Positives = 16/24 (66%), Gaps = 1/24 (4%)
Query: 73 LGQGGYGRVYKGKL-SDGRLVAVK 95
LG G YG V+K + DGRL AVK
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVK 88
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 26.2 bits (56), Expect = 7.8, Method: Compositional matrix adjust.
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 71 DELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNG-------QEFINEVASISRTSHVNV 122
+ELG G + V K + S G A K + + +E EV+ + + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+TL + LI E + G L F
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDF 105
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 26.2 bits (56), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 71 DELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNG-------QEFINEVASISRTSHVNV 122
+ELG G + V K + S G A K + + +E EV+ + + H NV
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+TL + LI E + G L F
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDF 105
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 26.2 bits (56), Expect = 8.4, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 36/88 (40%), Gaps = 8/88 (9%)
Query: 71 DELGQGGYGRVYKGKL-SDGRLVAVKLLNTSKGNG-------QEFINEVASISRTSHVNV 122
+ELG G + V K + S G A K + + +E EV+ + + H NV
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 123 VTLLGFCLEGSKRALIYEFMPNGSLEKF 150
+TL + LI E + G L F
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDF 105
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 25.8 bits (55), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 11/30 (36%), Positives = 21/30 (70%), Gaps = 1/30 (3%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSK 101
+G+GG+G VY + +D G++ A+K L+ +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 25.8 bits (55), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 11/30 (36%), Positives = 21/30 (70%), Gaps = 1/30 (3%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSK 101
+G+GG+G VY + +D G++ A+K L+ +
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR 226
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 25.8 bits (55), Expect = 9.6, Method: Compositional matrix adjust.
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 73 LGQGGYGRVY--KGKLS--DGRLVAVKLLNTSKGNGQEFINEVASISRTSHVNVVTLLGF 128
LG G YG V + K++ + + ++ + S + + + EVA + H N++ L F
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 129 CLEGSKRALIYEFMPNGSL 147
+ L+ E G L
Sbjct: 105 FEDKRNYYLVMECYKGGEL 123
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 25.8 bits (55), Expect = 10.0, Method: Compositional matrix adjust.
Identities = 11/30 (36%), Positives = 21/30 (70%), Gaps = 1/30 (3%)
Query: 73 LGQGGYGRVYKGKLSD-GRLVAVKLLNTSK 101
+G+GG+G VY + +D G++ A+K L+ +
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKR 225
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.136 0.397
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 4,072,990
Number of Sequences: 62578
Number of extensions: 159372
Number of successful extensions: 1102
Number of sequences better than 100.0: 558
Number of HSP's better than 100.0 without gapping: 279
Number of HSP's successfully gapped in prelim test: 279
Number of HSP's that attempted gapping in prelim test: 628
Number of HSP's gapped (non-prelim): 559
length of query: 150
length of database: 14,973,337
effective HSP length: 90
effective length of query: 60
effective length of database: 9,341,317
effective search space: 560479020
effective search space used: 560479020
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 47 (22.7 bits)